Background  	Background  	 NN	O
The  	The  	 DT	O
p53  	p53  	 NN	B-NP
tumor  	tumor  	 NN	I-NP
suppressor  	suppressor  	 NN	I-NP
gene  	gene  	 NN	I-NP
is  	is  	 VBZ	O
activated  	activated  	 VBN	O
during  	during  	 IN	O
several  	several  	 JJ	O
cellular  	cellular  	 JJ	B-NP
processes 	processes 	 NNS	I-NP
.  	.  	 .	O
These  	These  	 DT	O
include  	include  	 JJ	O
DNA  	DNA  	 NN	B-NP
damage  	damage  	 NN	I-NP
caused  	caused  	 VBN	O
by  	by  	 IN	O
Ionizing  	Ionizing  	 NNP	B-NP
Radiation  	Radiation  	 NNP	I-NP
and  	and  	 CC	O
genotoxic  	genotoxic  	 JJ	B-NP
agents  	agents  	 NNS	I-NP
[  	[  	 -LRB-	O
1 	1 	 LS	O
] 	] 	 -RRB-	O
,  	,  	 ,	O
by  	by  	 IN	O
expression  	expression  	 NN	O
of  	of  	 IN	O
activated  	activated  	 JJ	O
oncogenes  	oncogenes  	 NNS	B-NP
such  	such  	 JJ	O
as  	as  	 IN	O
ras  	ras  	 NN	B-NP
or  	or  	 CC	O
myc  	myc  	 NNS	B-NP
[  	[  	 -LRB-	O
2 	2 	 LS	O
] 	] 	 -RRB-	O
,  	,  	 ,	O
or  	or  	 CC	O
during  	during  	 IN	O
progression  	progression  	 NN	O
of  	of  	 IN	O
primary  	primary  	 JJ	B-NP
cells  	cells  	 NNS	I-NP
to  	to  	 TO	O
senescence  	senescence  	 VB	O
[  	[  	 -LRB-	O
3 	3 	 LS	O
] 	] 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
activation  	activation  	 NN	B-NP
of  	of  	 IN	I-NP
p53  	p53  	 NN	I-NP
by  	by  	 IN	O
these  	these  	 DT	O
diverse  	diverse  	 JJ	B-NP
stimuli  	stimuli  	 NNS	I-NP
can  	can  	 MD	O
initiate  	initiate  	 VB	O
either  	either  	 DT	O
growth  	growth  	 NN	B-NP
arrest  	arrest  	 NN	I-NP
or  	or  	 CC	O
apoptosis  	apoptosis  	 VBP	O
depending  	depending  	 VBG	O
on  	on  	 IN	O
the  	the  	 DT	O
cellular  	cellular  	 JJ	B-NP
context  	context  	 NN	I-NP
[  	[  	 -LRB-	O
1 	1 	 CD	O
,  	,  	 ,	O
2 	2 	 CD	O
,  	,  	 ,	O
3 	3 	 LS	O
] 	] 	 -RRB-	O
.  	.  	 .	O
p53  	p53  	 FW	B-NP
posses  	posses  	 FW	I-NP
sequence-specific  	sequence-specific  	 FW	I-NP
DNA  	DNA  	 NNP	I-NP
binding  	binding  	 JJ	O
activity  	activity  	 NN	O
and  	and  	 CC	O
functions  	functions  	 NNS	O
in  	in  	 IN	O
the  	the  	 DT	O
cell  	cell  	 NN	O
as  	as  	 IN	O
a  	a  	 DT	O
transcriptional  	transcriptional  	 JJ	B-NP
regulator 	regulator 	 NN	I-NP
.  	.  	 .	O
Many  	Many  	 JJ	O
p53  	p53  	 NN	B-NP
regulated  	regulated  	 VBN	I-NP
genes  	genes  	 NNS	I-NP
have  	have  	 VBP	O
been  	been  	 VBN	O
identified  	identified  	 VBN	O
[  	[  	 -LRB-	O
3 	3 	 LS	O
,  	,  	 ,	O
4 	4 	 CD	O
,  	,  	 ,	O
5 	5 	 CD	O
] 	] 	 -RRB-	O
,  	,  	 ,	O
and  	and  	 CC	O
the  	the  	 DT	O
majority  	majority  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
cellular  	cellular  	 JJ	B-NP
effects  	effects  	 NNS	I-NP
of  	of  	 IN	I-NP
p53  	p53  	 NN	I-NP
activation  	activation  	 NNS	I-NP
can  	can  	 MD	O
be  	be  	 VB	O
attributed  	attributed  	 VBN	O
to  	to  	 TO	O
the  	the  	 DT	O
activation  	activation  	 NN	B-NP
of  	of  	 IN	O
these  	these  	 DT	O
p53  	p53  	 NN	B-NP
target  	target  	 NN	I-NP
genes 	genes 	 NNS	I-NP
.  	.  	 .	O
The  	The  	 DT	O
mechanism  	mechanism  	 NN	O
of  	of  	 IN	O
p53  	p53  	 NN	B-NP
activation  	activation  	 NN	I-NP
in  	in  	 IN	O
response  	response  	 NN	O
to  	to  	 TO	O
either  	either  	 DT	O
DNA  	DNA  	 NN	B-NP
damage  	damage  	 NN	I-NP
or  	or  	 CC	O
oncogene  	oncogene  	 JJ	B-NP
expression  	expression  	 NN	I-NP
occurs  	occurs  	 VBZ	O
through  	through  	 IN	O
stabilization  	stabilization  	 NN	B-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
p53  	p53  	 NN	I-NP
protein 	protein 	 NN	I-NP
.  	.  	 .	O
In  	In  	 IN	O
unstimulated  	unstimulated  	 JJ	B-NP
cells 	cells 	 NNS	I-NP
,  	,  	 ,	O
the  	the  	 DT	O
mdm2  	mdm2  	 JJ	B-NP
protein  	protein  	 NN	I-NP
binds  	binds  	 NN	I-NP
to  	to  	 TO	O
the  	the  	 DT	O
N-terminal  	N-terminal  	 JJ	B-NP
transactivation  	transactivation  	 JJ	I-NP
domain  	domain  	 NN	I-NP
of  	of  	 IN	I-NP
p53  	p53  	 NN	I-NP
and  	and  	 CC	O
targets  	targets  	 NNS	O
it  	it  	 PRP	O
for  	for  	 IN	O
ubiquitin-dependent  	ubiquitin-dependent  	 JJ	B-NP
degradation  	degradation  	 NNS	I-NP
[  	[  	 -LRB-	O
6 	6 	 CD	O
,  	,  	 ,	O
7 	7 	 CD	O
] 	] 	 -RRB-	O
.  	.  	 .	O
Activation  	Activation  	 NNP	B-NP
of  	of  	 IN	I-NP
p53  	p53  	 NN	I-NP
requires  	requires  	 VBZ	O
disruption  	disruption  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
mdm2-p53  	mdm2-p53  	 JJ	B-NP
interaction  	interaction  	 NN	I-NP
to  	to  	 TO	O
allow  	allow  	 VB	O
p53  	p53  	 NN	B-NP
accumulation  	accumulation  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
cell.  	cell.  	 CD	O
2  	2  	 CD	O
distinct  	distinct  	 JJ	O
mechanisms  	mechanisms  	 NNS	O
for  	for  	 IN	O
p53  	p53  	 NN	B-NP
activation  	activation  	 NNS	I-NP
have  	have  	 VBP	O
so  	so  	 RB	O
far  	far  	 RB	O
been  	been  	 VBN	O
elucidated 	elucidated 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
expression  	expression  	 NN	O
of  	of  	 IN	O
oncogenes  	oncogenes  	 JJ	O
such  	such  	 JJ	O
as  	as  	 IN	O
ras  	ras  	 NN	B-NP
in  	in  	 IN	O
untransformed  	untransformed  	 JJ	B-NP
cells  	cells  	 NNS	I-NP
stimulates  	stimulates  	 VBP	O
transcription  	transcription  	 VBN	B-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
p14  	p14  	 NNP	I-NP
Arfgene  	Arfgene  	 NNP	I-NP
[  	[  	 -LRB-	O
2 	2 	 LS	O
] 	] 	 -RRB-	O
.  	.  	 .	O
p14  	p14  	 FW	B-NP
Arfbinds  	Arfbinds  	 FW	I-NP
to  	to  	 TO	O
and  	and  	 CC	O
sequesters  	sequesters  	 CD	O
mdm2 	mdm2 	 CD	B-NP
,  	,  	 ,	O
allowing  	allowing  	 VBG	O
free  	free  	 JJ	O
p53  	p53  	 NN	B-NP
protein  	protein  	 NN	I-NP
to  	to  	 TO	O
accumulate  	accumulate  	 VB	O
in  	in  	 IN	O
the  	the  	 DT	O
cells  	cells  	 NNS	O
[  	[  	 -LRB-	O
8 	8 	 CD	O
] 	] 	 -RRB-	O
.  	.  	 .	O
Activation  	Activation  	 NNP	B-NP
of  	of  	 IN	I-NP
p53  	p53  	 NN	I-NP
by  	by  	 IN	O
DNA  	DNA  	 NNP	B-NP
damage  	damage  	 NN	I-NP
is  	is  	 VBZ	O
also  	also  	 RB	O
brought  	brought  	 VBN	O
about  	about  	 RB	O
by  	by  	 IN	O
inhibition  	inhibition  	 NN	O
of  	of  	 IN	O
p53-mdm2  	p53-mdm2  	 CD	B-NP
interaction 	interaction 	 NNS	I-NP
.  	.  	 .	O
The  	The  	 DT	O
product  	product  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
Ataxia  	Ataxia  	 NNP	B-NP
Telangiectasia  	Telangiectasia  	 NNP	I-NP
gene 	gene 	 NN	I-NP
,  	,  	 ,	O
the  	the  	 DT	O
ATM  	ATM  	 NNP	B-NP
protein  	protein  	 NN	I-NP
kinase  	kinase  	 NNS	I-NP
[  	[  	 -LRB-	O
9 	9 	 CD	O
] 	] 	 -RRB-	O
,  	,  	 ,	O
directly  	directly  	 RB	O
phosphorylates  	phosphorylates  	 CD	B-NP
serine  	serine  	 CD	I-NP
15  	15  	 CD	O
of  	of  	 IN	O
the  	the  	 DT	O
p53  	p53  	 NN	B-NP
protein  	protein  	 NN	I-NP
in  	in  	 IN	O
response  	response  	 NN	O
to  	to  	 TO	O
Ionizing  	Ionizing  	 NNP	B-NP
Radiation  	Radiation  	 NNP	I-NP
[  	[  	 -LRB-	O
10 	10 	 CD	O
,  	,  	 ,	O
11 	11 	 CD	O
] 	] 	 -RRB-	O
.  	.  	 .	O
In  	In  	 IN	O
addition 	addition 	 NN	B-NP
,  	,  	 ,	O
ATM  	ATM  	 NNP	B-NP
phosphorylates  	phosphorylates  	 NN	I-NP
and  	and  	 CC	O
activates  	activates  	 FW	O
chk2  	chk2  	 FW	B-NP
kinase  	kinase  	 FW	I-NP
[  	[  	 -LRB-	O
12 	12 	 CD	O
] 	] 	 -RRB-	O
.  	.  	 .	O
Activated  	Activated  	 NNP	B-NP
chk2  	chk2  	 NNP	I-NP
can  	can  	 MD	O
then  	then  	 RB	O
directly  	directly  	 RB	O
phosphorylate  	phosphorylate  	 CD	B-NP
serine  	serine  	 CD	I-NP
20  	20  	 CD	O
of  	of  	 IN	O
p53  	p53  	 NN	B-NP
[  	[  	 -LRB-	O
13 	13 	 CD	O
,  	,  	 ,	O
14 	14 	 CD	O
] 	] 	 -RRB-	O
.  	.  	 .	O
ATM  	ATM  	 NNP	B-NP
therefore  	therefore  	 RB	O
controls  	controls  	 VBZ	O
the  	the  	 DT	O
phosphorylation  	phosphorylation  	 NN	B-NP
of  	of  	 IN	I-NP
serines  	serines  	 CD	I-NP
15  	15  	 CD	O
and  	and  	 CC	O
20  	20  	 CD	O
of  	of  	 IN	O
p53 	p53 	 NN	B-NP
.  	.  	 .	O
In  	In  	 IN	O
addition 	addition 	 NN	B-NP
,  	,  	 ,	O
DNA  	DNA  	 NNP	B-NP
damage  	damage  	 NN	I-NP
increases  	increases  	 VBZ	O
the  	the  	 DT	O
phosphorylation  	phosphorylation  	 NN	B-NP
of  	of  	 IN	I-NP
serines  	serines  	 CD	I-NP
33  	33  	 CD	O
and  	and  	 CC	O
37  	37  	 CD	O
of  	of  	 IN	O
p53  	p53  	 NN	B-NP
through  	through  	 IN	O
an  	an  	 DT	O
ATM-independent  	ATM-independent  	 JJ	B-NP
mechanism  	mechanism  	 NN	I-NP
[  	[  	 -LRB-	O
15 	15 	 CD	O
,  	,  	 ,	O
16 	16 	 CD	O
,  	,  	 ,	O
17 	17 	 CD	O
,  	,  	 ,	O
18 	18 	 CD	O
] 	] 	 -RRB-	O
.  	.  	 .	O
These  	These  	 DT	O
DNA  	DNA  	 NN	B-NP
damage-induced  	damage-induced  	 JJ	O
phosphorylations  	phosphorylations  	 NN	B-NP
of  	of  	 IN	I-NP
p53  	p53  	 NN	I-NP
block  	block  	 VB	O
the  	the  	 DT	O
binding  	binding  	 NN	O
of  	of  	 IN	O
mdm2  	mdm2  	 CD	B-NP
to  	to  	 TO	O
the  	the  	 DT	O
N-terminal  	N-terminal  	 JJ	B-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
p53  	p53  	 NN	I-NP
protein  	protein  	 NN	I-NP
[  	[  	 -LRB-	O
18 	18 	 CD	O
] 	] 	 -RRB-	O
.  	.  	 .	O
Thus  	Thus  	 RB	O
phosphorylation  	phosphorylation  	 VBN	O
of  	of  	 IN	O
the  	the  	 DT	O
p53  	p53  	 NN	B-NP
protein  	protein  	 NN	I-NP
in  	in  	 IN	O
response  	response  	 NN	O
to  	to  	 TO	O
DNA  	DNA  	 NNP	B-NP
damage  	damage  	 NN	I-NP
or  	or  	 CC	O
expression  	expression  	 NN	O
of  	of  	 IN	O
p14Arf  	p14Arf  	 NNP	O
prevents  	prevents  	 VBZ	O
mdm2  	mdm2  	 CD	B-NP
binding  	binding  	 NNS	O
and  	and  	 CC	O
p53  	p53  	 NN	B-NP
protein  	protein  	 NN	I-NP
then  	then  	 RB	O
accumulates  	accumulates  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
cell 	cell 	 NN	O
.  	.  	 .	O
Although  	Although  	 IN	O
stabilization  	stabilization  	 NN	B-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
p53  	p53  	 NN	I-NP
protein  	protein  	 NN	I-NP
is  	is  	 VBZ	O
the  	the  	 DT	O
initial  	initial  	 JJ	O
step  	step  	 NN	O
in  	in  	 IN	O
p53  	p53  	 NN	B-NP
activation 	activation 	 NN	I-NP
,  	,  	 ,	O
subsequent  	subsequent  	 JJ	O
steps 	steps 	 NNS	O
,  	,  	 ,	O
including  	including  	 VBG	B-NP
activation  	activation  	 NN	I-NP
of  	of  	 IN	O
p53 	p53 	 NN	O
's  	's  	 POS	O
DNA  	DNA  	 NN	B-NP
binding  	binding  	 JJ	O
activity  	activity  	 NN	O
and  	and  	 CC	O
changes  	changes  	 NNS	O
in  	in  	 IN	O
p53 	p53 	 NN	O
's  	's  	 POS	O
transcriptional  	transcriptional  	 JJ	B-NP
activity 	activity 	 NN	I-NP
,  	,  	 ,	O
are  	are  	 VBP	O
also  	also  	 RB	O
involved 	involved 	 VBN	O
.  	.  	 .	O
For  	For  	 IN	O
example 	example 	 NN	O
,  	,  	 ,	O
p53 	p53 	 NN	O
's  	's  	 POS	O
DNA  	DNA  	 NN	B-NP
binding  	binding  	 JJ	O
activity  	activity  	 NN	O
is  	is  	 VBZ	O
increased  	increased  	 VBN	O
by  	by  	 IN	O
the  	the  	 DT	O
DNA  	DNA  	 NN	B-NP
damage-induced  	damage-induced  	 JJ	O
acetylation  	acetylation  	 NN	B-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
C-terminal  	C-terminal  	 JJ	I-NP
of  	of  	 IN	I-NP
p53  	p53  	 NN	I-NP
[  	[  	 -LRB-	O
16 	16 	 CD	O
,  	,  	 ,	O
19 	19 	 CD	O
] 	] 	 -RRB-	O
,  	,  	 ,	O
and  	and  	 CC	O
this  	this  	 DT	O
acetylation  	acetylation  	 NN	B-NP
requires  	requires  	 VBZ	O
the  	the  	 DT	O
prior  	prior  	 JJ	O
phosphorylation  	phosphorylation  	 NN	B-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
N-terminal  	N-terminal  	 JJ	I-NP
of  	of  	 IN	I-NP
p53  	p53  	 NN	I-NP
[  	[  	 -LRB-	O
16 	16 	 CD	O
] 	] 	 -RRB-	O
.  	.  	 .	O
In  	In  	 IN	O
addition 	addition 	 NN	B-NP
,  	,  	 ,	O
phosphorylation  	phosphorylation  	 VBG	O
of  	of  	 IN	O
the  	the  	 DT	O
N-terminal  	N-terminal  	 JJ	B-NP
transactivation  	transactivation  	 JJ	I-NP
domain  	domain  	 NN	I-NP
of  	of  	 IN	I-NP
p53  	p53  	 NN	I-NP
may  	may  	 MD	O
be  	be  	 VB	O
required  	required  	 VBN	O
to  	to  	 TO	O
stimulate  	stimulate  	 VB	O
transcriptional  	transcriptional  	 JJ	B-NP
activation  	activation  	 NN	I-NP
of  	of  	 IN	I-NP
p53  	p53  	 NN	I-NP
target  	target  	 NN	I-NP
genes 	genes 	 NNS	I-NP
.  	.  	 .	O
Multiple  	Multiple  	 JJ	B-NP
phosphorylation  	phosphorylation  	 JJ	I-NP
sites  	sites  	 NNS	I-NP
have  	have  	 VBP	O
been  	been  	 VBN	O
detected  	detected  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
N-terminal  	N-terminal  	 JJ	B-NP
of  	of  	 IN	I-NP
p53 	p53 	 NN	I-NP
,  	,  	 ,	O
including  	including  	 VBG	B-NP
serines  	serines  	 CD	I-NP
6 	6 	 CD	O
,  	,  	 ,	O
9 	9 	 CD	O
,  	,  	 ,	O
15 	15 	 CD	O
,  	,  	 ,	O
20 	20 	 CD	O
,  	,  	 ,	O
33 	33 	 CD	O
,  	,  	 ,	O
37  	37  	 CD	O
and  	and  	 CC	O
46  	46  	 CD	O
[  	[  	 -LRB-	O
10 	10 	 CD	O
,  	,  	 ,	O
11 	11 	 CD	O
,  	,  	 ,	O
12 	12 	 CD	O
,  	,  	 ,	O
13 	13 	 CD	O
,  	,  	 ,	O
14 	14 	 CD	O
,  	,  	 ,	O
20 	20 	 CD	O
,  	,  	 ,	O
21 	21 	 CD	O
,  	,  	 ,	O
22 	22 	 CD	O
] 	] 	 -RRB-	O
.  	.  	 .	O
While  	While  	 IN	O
phosphorylation  	phosphorylation  	 NN	B-NP
of  	of  	 IN	I-NP
serines  	serines  	 CD	I-NP
15  	15  	 CD	O
and  	and  	 CC	O
20  	20  	 CD	O
of  	of  	 IN	O
p53  	p53  	 NN	B-NP
are  	are  	 VBP	O
clearly  	clearly  	 RB	O
dependent  	dependent  	 JJ	O
on  	on  	 IN	O
the  	the  	 DT	O
ATM  	ATM  	 NNP	B-NP
and  	and  	 CC	O
chk2  	chk2  	 CD	B-NP
protein  	protein  	 NN	I-NP
kinases  	kinases  	 NNS	I-NP
[  	[  	 -LRB-	O
10 	10 	 CD	O
,  	,  	 ,	O
11 	11 	 CD	O
,  	,  	 ,	O
12 	12 	 CD	O
,  	,  	 ,	O
13 	13 	 CD	O
,  	,  	 ,	O
14 	14 	 CD	O
] 	] 	 -RRB-	O
,  	,  	 ,	O
the  	the  	 DT	O
kinases  	kinases  	 JJ	B-NP
responsible  	responsible  	 JJ	I-NP
for  	for  	 IN	I-NP
phosphorylation  	phosphorylation  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
remaining  	remaining  	 JJ	O
serine  	serine  	 JJ	B-NP
residues  	residues  	 NNS	I-NP
in  	in  	 IN	O
vivo  	vivo  	 NN	B-NP
is  	is  	 VBZ	O
not  	not  	 RB	O
clear 	clear 	 JJ	O
.  	.  	 .	O
The  	The  	 DT	O
activation  	activation  	 NN	B-NP
of  	of  	 IN	I-NP
p53  	p53  	 NN	I-NP
by  	by  	 IN	O
DNA  	DNA  	 NNP	B-NP
damage  	damage  	 NN	I-NP
or  	or  	 CC	O
oncogenes  	oncogenes  	 JJ	O
such  	such  	 JJ	O
as  	as  	 IN	O
ras  	ras  	 JJ	B-NP
results  	results  	 NNS	I-NP
in  	in  	 IN	O
either  	either  	 DT	O
growth  	growth  	 NN	B-NP
arrest  	arrest  	 NN	I-NP
or  	or  	 CC	O
apoptosis  	apoptosis  	 NN	B-NP
of  	of  	 IN	O
the  	the  	 DT	O
affected  	affected  	 JJ	O
cell 	cell 	 NN	O
.  	.  	 .	O
In  	In  	 IN	O
this  	this  	 DT	O
study 	study 	 NN	O
,  	,  	 ,	O
we  	we  	 PRP	O
have  	have  	 VBP	O
examined  	examined  	 VBN	O
how  	how  	 WRB	O
Glycogen  	Glycogen  	 NNP	O
Synthase  	Synthase  	 NNP	O
Kinase  	Kinase  	 NNP	O
3β  	3β  	 NNP	O
( 	( 	 -LRB-	O
GSK3β 	GSK3β 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
a  	a  	 DT	O
protein  	protein  	 NN	B-NP
kinase  	kinase  	 VBZ	O
involved  	involved  	 VBN	O
in  	in  	 IN	O
tumorigenesis 	tumorigenesis 	 NN	B-NP
,  	,  	 ,	O
differentiation  	differentiation  	 NN	B-NP
and  	and  	 CC	O
apoptosis 	apoptosis 	 NN	B-NP
,  	,  	 ,	O
regulates  	regulates  	 VBZ	O
the  	the  	 DT	O
function  	function  	 NN	O
of  	of  	 IN	O
p53  	p53  	 NN	B-NP
[  	[  	 -LRB-	O
23 	23 	 CD	O
,  	,  	 ,	O
24 	24 	 CD	O
] 	] 	 -RRB-	O
.  	.  	 .	O
GSK3β  	GSK3β  	 NNP	B-NP
phosphorylates  	phosphorylates  	 VBD	O
several  	several  	 JJ	O
transcription  	transcription  	 JJ	B-NP
factors 	factors 	 NNS	I-NP
,  	,  	 ,	O
including  	including  	 VBG	O
NFATc  	NFATc  	 JJ	O
and  	and  	 CC	O
HSF1  	HSF1  	 NNP	B-NP
[  	[  	 -LRB-	O
24 	24 	 CD	O
,  	,  	 ,	O
25 	25 	 CD	O
,  	,  	 ,	O
26 	26 	 CD	O
,  	,  	 ,	O
27 	27 	 CD	O
] 	] 	 -RRB-	O
.  	.  	 .	O
GSK3β  	GSK3β  	 NNP	B-NP
is  	is  	 VBZ	O
constitutively  	constitutively  	 JJ	O
active  	active  	 JJ	O
in  	in  	 IN	O
resting  	resting  	 JJ	O
cells  	cells  	 NNS	O
but  	but  	 CC	O
is  	is  	 VBZ	O
inhibited  	inhibited  	 VBN	O
when  	when  	 WRB	O
cells  	cells  	 NNS	O
are  	are  	 VBP	O
exposed  	exposed  	 VBN	O
to  	to  	 TO	O
growth  	growth  	 NN	B-NP
factors  	factors  	 NNS	I-NP
[  	[  	 -LRB-	O
24 	24 	 CD	O
,  	,  	 ,	O
28 	28 	 CD	O
] 	] 	 -RRB-	O
.  	.  	 .	O
GSK3  	GSK3  	 NNP	B-NP
inhibition  	inhibition  	 NN	I-NP
occurs  	occurs  	 VBZ	O
when  	when  	 WRB	O
the  	the  	 DT	O
p110-PI  	p110-PI  	 NNP	O
3-kinase 	3-kinase 	 NNP	O
/ 	/ 	 NNP	O
Protein  	Protein  	 NNP	B-NP
Kinase  	Kinase  	 NNP	I-NP
B  	B  	 NNP	I-NP
( 	( 	 -LRB-	O
PKB 	PKB 	 NNP	B-NP
)  	)  	 -RRB-	O
pathway  	pathway  	 NN	O
is  	is  	 VBZ	O
activated  	activated  	 VBN	O
by  	by  	 IN	O
growth  	growth  	 NN	B-NP
factors  	factors  	 NNS	I-NP
[  	[  	 -LRB-	O
23 	23 	 CD	O
,  	,  	 ,	O
24 	24 	 CD	O
,  	,  	 ,	O
25 	25 	 CD	O
,  	,  	 ,	O
29 	29 	 CD	O
] 	] 	 -RRB-	O
.  	.  	 .	O
Activated  	Activated  	 NNP	B-NP
PKB  	PKB  	 NNP	I-NP
then  	then  	 RB	O
phosphorylates  	phosphorylates  	 CD	B-NP
GSK3β 	GSK3β 	 CD	I-NP
,  	,  	 ,	O
inhibiting  	inhibiting  	 FW	B-NP
GSK3  	GSK3  	 FW	I-NP
kinase  	kinase  	 FW	I-NP
activity  	activity  	 FW	I-NP
[  	[  	 -LRB-	O
29 	29 	 CD	O
] 	] 	 -RRB-	O
.  	.  	 .	O
This  	This  	 DT	O
activation  	activation  	 NN	B-NP
of  	of  	 IN	O
the  	the  	 DT	O
p110-PI  	p110-PI  	 NNP	O
3-kinase 	3-kinase 	 NNP	O
/ 	/ 	 NNP	O
PKB  	PKB  	 NNP	O
pathway 	pathway 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
inhibition  	inhibition  	 NN	O
of  	of  	 IN	O
GSK3 	GSK3 	 NNP	B-NP
,  	,  	 ,	O
delivers  	delivers  	 VBZ	O
a  	a  	 DT	O
strong  	strong  	 JJ	O
anti-apoptotic  	anti-apoptotic  	 JJ	B-NP
signal  	signal  	 NN	I-NP
to  	to  	 TO	O
the  	the  	 DT	O
cell  	cell  	 NN	O
[  	[  	 -LRB-	O
23 	23 	 CD	O
,  	,  	 ,	O
24 	24 	 CD	O
,  	,  	 ,	O
25 	25 	 CD	O
] 	] 	 -RRB-	O
.  	.  	 .	O
Given  	Given  	 VBN	O
the  	the  	 DT	O
well  	well  	 RB	O
characterized  	characterized  	 VBN	O
role  	role  	 NN	O
of  	of  	 IN	O
p53  	p53  	 NN	B-NP
in  	in  	 IN	O
apoptosis  	apoptosis  	 NNS	B-NP
[  	[  	 -LRB-	O
3 	3 	 LS	O
,  	,  	 ,	O
4 	4 	 CD	O
,  	,  	 ,	O
5 	5 	 CD	O
] 	] 	 -RRB-	O
,  	,  	 ,	O
we  	we  	 PRP	O
examined  	examined  	 VBD	O
if  	if  	 IN	O
GSK3p  	GSK3p  	 CD	O
participates  	participates  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
regulation  	regulation  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
p53  	p53  	 NN	B-NP
protein 	protein 	 NN	I-NP
.  	.  	 .	O
GSK3  	GSK3  	 NNP	B-NP
phosphorylates  	phosphorylates  	 VBD	O
the  	the  	 DT	O
consensus  	consensus  	 NN	B-NP
sequence  	sequence  	 NN	I-NP
Ser-X-X-X-Ser 	Ser-X-X-X-Ser 	 NNS	I-NP
( 	( 	 -LRB-	I-NP
P 	P 	 NN	I-NP
) 	) 	 -RRB-	I-NP
,  	,  	 ,	O
where  	where  	 WRB	O
the  	the  	 DT	O
C-terminal  	C-terminal  	 JJ	B-NP
serine  	serine  	 JJ	I-NP
residue  	residue  	 NN	I-NP
is  	is  	 VBZ	O
already  	already  	 RB	O
phosphorylated  	phosphorylated  	 JJ	O
[  	[  	 -LRB-	O
24 	24 	 CD	O
,  	,  	 ,	O
28 	28 	 CD	O
] 	] 	 -RRB-	O
.  	.  	 .	O
Thus  	Thus  	 RB	O
GSK3  	GSK3  	 RB	O
only  	only  	 RB	O
phosphorylates  	phosphorylates  	 JJ	B-NP
target  	target  	 NN	I-NP
proteins  	proteins  	 NNS	I-NP
which  	which  	 WDT	O
have  	have  	 VBP	O
already  	already  	 RB	O
been  	been  	 VBN	O
phosphorylated  	phosphorylated  	 VBN	O
by  	by  	 IN	O
a  	a  	 DT	O
separate 	separate 	 JJ	O
,  	,  	 ,	O
priming  	priming  	 CD	B-NP
kinase.  	kinase.  	 CD	I-NP
p53  	p53  	 NN	O
contains  	contains  	 VBZ	O
5  	5  	 CD	O
potential  	potential  	 JJ	B-NP
GSK3  	GSK3  	 CD	I-NP
phosphorylation  	phosphorylation  	 CD	I-NP
sites 	sites 	 NNS	I-NP
,  	,  	 ,	O
3  	3  	 CD	O
in  	in  	 IN	O
the  	the  	 DT	O
N-terminal  	N-terminal  	 JJ	B-NP
transactivation  	transactivation  	 JJ	I-NP
domain  	domain  	 NN	I-NP
and  	and  	 CC	O
2  	2  	 CD	O
in  	in  	 IN	O
the  	the  	 DT	O
C-terminal  	C-terminal  	 JJ	B-NP
regulatory  	regulatory  	 JJ	I-NP
domain 	domain 	 NN	I-NP
.  	.  	 .	O
Here 	Here 	 RB	O
,  	,  	 ,	O
we  	we  	 PRP	O
show  	show  	 VBP	O
that  	that  	 IN	O
GSK3β 	GSK3β 	 NNP	B-NP
,  	,  	 ,	O
but  	but  	 CC	O
not  	not  	 RB	O
GSK3α 	GSK3α 	 CD	B-NP
,  	,  	 ,	O
can  	can  	 MD	O
phosphorylate  	phosphorylate  	 VB	O
serine  	serine  	 CD	B-NP
33  	33  	 CD	O
of  	of  	 IN	O
p53  	p53  	 NN	B-NP
in  	in  	 IN	O
vitro  	vitro  	 NN	B-NP
when  	when  	 WRB	O
serine  	serine  	 JJ	O
37  	37  	 CD	O
is  	is  	 VBZ	O
already  	already  	 RB	O
phosphorylated 	phosphorylated 	 VBN	O
.  	.  	 .	O
Further 	Further 	 RB	O
,  	,  	 ,	O
GSK3β  	GSK3β  	 NNP	B-NP
can  	can  	 MD	O
increase  	increase  	 VB	O
p53 	p53 	 NN	O
's  	's  	 POS	O
transcriptional  	transcriptional  	 JJ	B-NP
activity  	activity  	 NN	I-NP
in  	in  	 IN	O
vivo 	vivo 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
this  	this  	 DT	O
activation  	activation  	 NN	B-NP
is  	is  	 VBZ	O
lost  	lost  	 VBN	O
when  	when  	 WRB	O
serine  	serine  	 JJ	O
33  	33  	 CD	O
is  	is  	 VBZ	O
mutated  	mutated  	 VBN	O
to  	to  	 TO	O
alanine 	alanine 	 VB	O
.  	.  	 .	O
Results  	Results  	 NNS	O
The  	The  	 DT	O
p53  	p53  	 NN	B-NP
protein  	protein  	 NN	I-NP
contains  	contains  	 VBZ	O
several  	several  	 JJ	O
serine  	serine  	 JJ	B-NP
residues  	residues  	 NNS	I-NP
which  	which  	 WDT	O
are  	are  	 VBP	O
located  	located  	 VBN	O
within  	within  	 IN	O
potential  	potential  	 JJ	B-NP
GSK3  	GSK3  	 CD	I-NP
phosphorylation  	phosphorylation  	 CD	I-NP
sites 	sites 	 NNS	I-NP
.  	.  	 .	O
Protein  	Protein  	 NN	B-NP
kinases  	kinases  	 NNS	I-NP
which  	which  	 WDT	O
can  	can  	 MD	O
phosphorylate  	phosphorylate  	 VB	O
p53  	p53  	 NN	B-NP
within  	within  	 IN	O
these  	these  	 DT	O
predicted  	predicted  	 VBD	B-NP
GSK3  	GSK3  	 CD	I-NP
sites  	sites  	 NNS	I-NP
include  	include  	 VBP	O
MAP  	MAP  	 JJ	B-NP
kinase 	kinase 	 NN	I-NP
,  	,  	 ,	O
Protein  	Protein  	 NNP	B-NP
Kinase  	Kinase  	 NNP	I-NP
A 	A 	 NNP	O
,  	,  	 ,	O
Protein  	Protein  	 NNP	B-NP
Kinase  	Kinase  	 NNP	I-NP
C 	C 	 NNP	I-NP
,  	,  	 ,	O
Casein  	Casein  	 NNP	B-NP
Kinase  	Kinase  	 NNP	I-NP
II 	II 	 NNP	I-NP
,  	,  	 ,	O
Jun  	Jun  	 NNP	O
kinase  	kinase  	 NNS	B-NP
( 	( 	 -LRB-	O
JNK 	JNK 	 NNP	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
DNA-dependent  	DNA-dependent  	 NNP	B-NP
Protein  	Protein  	 NNP	I-NP
Kinase  	Kinase  	 NNP	I-NP
( 	( 	 -LRB-	O
DNA-PK 	DNA-PK 	 NNP	B-NP
)  	)  	 -RRB-	O
[  	[  	 -LRB-	O
30 	30 	 CD	O
,  	,  	 ,	O
31 	31 	 CD	O
,  	,  	 ,	O
32 	32 	 CD	O
,  	,  	 ,	O
33 	33 	 CD	O
,  	,  	 ,	O
34 	34 	 CD	O
,  	,  	 ,	O
35 	35 	 CD	O
] 	] 	 -RRB-	O
.  	.  	 .	O
These  	These  	 DT	O
kinases  	kinases  	 NN	B-NP
were  	were  	 VBD	O
examined  	examined  	 VBN	O
to  	to  	 TO	O
determine  	determine  	 VB	O
if  	if  	 IN	O
they  	they  	 PRP	O
can  	can  	 MD	O
act  	act  	 VB	O
as  	as  	 IN	O
the  	the  	 DT	O
priming  	priming  	 JJ	O
kinase  	kinase  	 NN	B-NP
for  	for  	 IN	O
either  	either  	 RB	O
of  	of  	 IN	O
the  	the  	 DT	O
2  	2  	 CD	O
isoforms  	isoforms  	 NN	B-NP
of  	of  	 IN	I-NP
GSK3 	GSK3 	 NNP	I-NP
,  	,  	 ,	O
GSK3α  	GSK3α  	 NNP	B-NP
and  	and  	 CC	O
GSK3β 	GSK3β 	 NNP	B-NP
.  	.  	 .	O
The  	The  	 DT	O
general  	general  	 JJ	O
protocol  	protocol  	 NN	O
was  	was  	 VBD	O
to  	to  	 TO	O
incubate  	incubate  	 VB	O
purified  	purified  	 JJ	O
priming  	priming  	 JJ	O
kinases  	kinases  	 NN	B-NP
with  	with  	 IN	O
p53-GST  	p53-GST  	 CD	B-NP
fusion  	fusion  	 NN	I-NP
protein  	protein  	 NN	I-NP
and  	and  	 CC	O
ATP  	ATP  	 NNP	B-NP
for  	for  	 IN	O
5  	5  	 CD	O
h 	h 	 NN	O
,  	,  	 ,	O
then  	then  	 RB	O
heat  	heat  	 VB	O
inactivate  	inactivate  	 VBN	O
the  	the  	 DT	O
priming  	priming  	 JJ	O
kinase 	kinase 	 NN	B-NP
.  	.  	 .	O
Preliminary  	Preliminary  	 JJ	B-NP
experiments  	experiments  	 NNS	I-NP
indicated  	indicated  	 VBD	O
that  	that  	 IN	O
each  	each  	 DT	O
of  	of  	 IN	O
the  	the  	 DT	O
tested  	tested  	 JJ	O
kinases  	kinases  	 NN	B-NP
was  	was  	 VBD	O
able  	able  	 JJ	O
to  	to  	 TO	O
phosphorylate  	phosphorylate  	 CD	B-NP
p53-GST  	p53-GST  	 CD	I-NP
under  	under  	 IN	O
the  	the  	 DT	O
experimental  	experimental  	 JJ	B-NP
conditions  	conditions  	 NNS	I-NP
( 	( 	 -LRB-	O
data  	data  	 NNS	O
not  	not  	 RB	O
shown 	shown 	 VBN	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Aliquots  	Aliquots  	 NNP	B-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
prephosphorylated  	prephosphorylated  	 JJ	I-NP
p53-GST  	p53-GST  	 NN	I-NP
were  	were  	 VBD	O
then  	then  	 RB	O
incubated  	incubated  	 VBN	O
with  	with  	 IN	O
or  	or  	 CC	O
without  	without  	 IN	O
recombinant  	recombinant  	 JJ	B-NP
GSK3α  	GSK3α  	 NN	I-NP
or  	or  	 CC	O
GSK3β  	GSK3β  	 NNP	B-NP
and  	and  	 CC	O
32P-ATP  	32P-ATP  	 CD	O
to  	to  	 TO	O
measure  	measure  	 VB	O
p53  	p53  	 CD	B-NP
phosphorylation.  	phosphorylation.  	 CD	I-NP
p53-GST  	p53-GST  	 CD	O
preincubated  	preincubated  	 NN	O
in  	in  	 IN	O
buffer  	buffer  	 NN	B-NP
alone 	alone 	 RB	O
,  	,  	 ,	O
and  	and  	 CC	O
then  	then  	 RB	O
exposed  	exposed  	 VBN	O
to  	to  	 TO	O
the  	the  	 DT	O
heat  	heat  	 NN	B-NP
inactivation  	inactivation  	 NN	I-NP
protocol  	protocol  	 NN	I-NP
was  	was  	 VBD	O
not  	not  	 RB	O
phosphorylated  	phosphorylated  	 VBN	O
by  	by  	 IN	O
either  	either  	 DT	O
GSK3α  	GSK3α  	 NNP	B-NP
or  	or  	 CC	O
GSK3β  	GSK3β  	 NNP	B-NP
( 	( 	 -LRB-	O
fig  	fig  	 CD	O
1 	1 	 CD	O
,  	,  	 ,	O
Control 	Control 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Autophosphorylation  	Autophosphorylation  	 NNP	B-NP
of  	of  	 IN	I-NP
GSK3α  	GSK3α  	 NNP	I-NP
and  	and  	 CC	O
GSK3β  	GSK3β  	 NNP	B-NP
can  	can  	 MD	O
be  	be  	 VB	O
seen  	seen  	 VBN	O
( 	( 	 -LRB-	O
figure  	figure  	 NN	O
1 	1 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Unphosphorylated  	Unphosphorylated  	 NNP	O
p53-GST  	p53-GST  	 NNP	B-NP
is  	is  	 VBZ	O
therefore  	therefore  	 RB	O
not  	not  	 RB	O
a  	a  	 DT	O
substrate  	substrate  	 NN	O
for  	for  	 IN	O
GSK3α  	GSK3α  	 NNP	B-NP
or  	or  	 CC	O
GSK3β  	GSK3β  	 CD	B-NP
in  	in  	 IN	O
vitro.  	vitro.  	 NNP	B-NP
p53-GST  	p53-GST  	 NNP	O
was  	was  	 VBD	O
then  	then  	 RB	O
prephosphorylated  	prephosphorylated  	 VBN	O
with  	with  	 IN	O
MAP  	MAP  	 NNP	B-NP
kinase 	kinase 	 NN	I-NP
,  	,  	 ,	O
S6  	S6  	 CD	B-NP
kinase 	kinase 	 NN	I-NP
,  	,  	 ,	O
Protein  	Protein  	 NNP	B-NP
Kinase  	Kinase  	 NNP	I-NP
A 	A 	 NNP	O
,  	,  	 ,	O
DNA-PK  	DNA-PK  	 JJ	B-NP
and  	and  	 CC	O
Protein  	Protein  	 NNP	B-NP
Kinase  	Kinase  	 NNP	I-NP
C  	C  	 NNP	I-NP
( 	( 	 -LRB-	O
fig  	fig  	 CD	O
1 	1 	 CD	O
)  	)  	 -RRB-	O
or  	or  	 CC	O
Casein  	Casein  	 NNP	B-NP
Kinase  	Kinase  	 NNP	I-NP
II  	II  	 NNP	I-NP
and  	and  	 CC	O
JNK1 	JNK1 	 NNP	B-NP
/ 	/ 	 NNP	O
JNK2  	JNK2  	 NNP	B-NP
( 	( 	 -LRB-	O
data  	data  	 NNS	O
not  	not  	 RB	O
shown 	shown 	 VBN	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Following  	Following  	 VBG	O
incubation  	incubation  	 NN	O
in  	in  	 IN	O
each  	each  	 DT	O
of  	of  	 IN	O
the  	the  	 DT	O
primary  	primary  	 JJ	B-NP
kinases 	kinases 	 NN	I-NP
,  	,  	 ,	O
the  	the  	 DT	O
prephosphorylated  	prephosphorylated  	 JJ	B-NP
p53-GST  	p53-GST  	 NN	I-NP
was  	was  	 VBD	O
then  	then  	 RB	O
incubated  	incubated  	 VBN	O
with  	with  	 IN	O
32P-ATP  	32P-ATP  	 NNP	O
and  	and  	 CC	O
either  	either  	 DT	O
GSK3α  	GSK3α  	 NNP	B-NP
or  	or  	 CC	O
GSK3β 	GSK3β 	 NNP	B-NP
.  	.  	 .	O
Prephosphorylation  	Prephosphorylation  	 NNP	B-NP
of  	of  	 IN	I-NP
p53-GST  	p53-GST  	 CD	I-NP
by  	by  	 IN	O
MAP  	MAP  	 NNP	B-NP
kinase 	kinase 	 NN	I-NP
,  	,  	 ,	O
S6  	S6  	 CD	B-NP
kinase 	kinase 	 NN	I-NP
,  	,  	 ,	O
Protein  	Protein  	 NNP	B-NP
Kinase  	Kinase  	 NNP	I-NP
A  	A  	 NNP	O
or  	or  	 CC	O
Protein  	Protein  	 NNP	B-NP
Kinase  	Kinase  	 NNP	I-NP
C  	C  	 NNP	I-NP
( 	( 	 -LRB-	O
fig  	fig  	 CD	O
1 	1 	 CD	O
)  	)  	 -RRB-	O
or  	or  	 CC	O
Casein  	Casein  	 NNP	B-NP
Kinase  	Kinase  	 NNP	I-NP
II  	II  	 NNP	I-NP
or  	or  	 CC	O
JNK1  	JNK1  	 NNP	B-NP
or  	or  	 CC	O
JNK  	JNK  	 NNP	B-NP
2  	2  	 CD	O
( 	( 	 -LRB-	O
data  	data  	 NNS	O
not  	not  	 RB	O
shown 	shown 	 VBN	O
)  	)  	 -RRB-	O
failed  	failed  	 VBD	O
to  	to  	 TO	O
create  	create  	 VB	O
a  	a  	 DT	O
phosphorylation  	phosphorylation  	 JJ	B-NP
site  	site  	 NN	I-NP
for  	for  	 IN	O
either  	either  	 DT	O
GSK3α  	GSK3α  	 NNP	B-NP
or  	or  	 CC	O
GSK3β 	GSK3β 	 NNP	B-NP
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
prephosphorylation  	prephosphorylation  	 VBG	O
of  	of  	 IN	O
p53-GST  	p53-GST  	 CD	B-NP
by  	by  	 IN	O
DNA-PK  	DNA-PK  	 NNP	B-NP
resulted  	resulted  	 VBD	O
in  	in  	 IN	O
strong  	strong  	 JJ	O
phosphorylation  	phosphorylation  	 NN	B-NP
of  	of  	 IN	I-NP
p53  	p53  	 NN	I-NP
by  	by  	 IN	O
GSK3β  	GSK3β  	 NNP	B-NP
( 	( 	 -LRB-	O
fig  	fig  	 CD	O
1 	1 	 CD	O
)  	)  	 -RRB-	O
but  	but  	 CC	O
not  	not  	 RB	O
GSK3α 	GSK3α 	 CD	B-NP
.  	.  	 .	O
GST  	GST  	 NNP	B-NP
protein  	protein  	 NN	I-NP
alone  	alone  	 RB	O
incubated  	incubated  	 VBN	O
with  	with  	 IN	O
DNA-PK  	DNA-PK  	 NNP	B-NP
was  	was  	 VBD	O
not  	not  	 RB	O
phosphorylated  	phosphorylated  	 VBN	O
by  	by  	 IN	O
GSK3β  	GSK3β  	 NNP	B-NP
( 	( 	 -LRB-	O
data  	data  	 NNS	O
not  	not  	 RB	O
shown 	shown 	 VBN	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Since  	Since  	 IN	O
there  	there  	 EX	O
was  	was  	 VBD	O
no  	no  	 DT	O
significant  	significant  	 JJ	O
phosphorylation  	phosphorylation  	 NN	B-NP
of  	of  	 IN	I-NP
p53-GST  	p53-GST  	 CD	I-NP
by  	by  	 IN	O
GSK3α  	GSK3α  	 NNP	B-NP
( 	( 	 -LRB-	O
fig  	fig  	 CD	O
1 	1 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
this  	this  	 DT	O
indicates  	indicates  	 VBZ	O
that  	that  	 DT	O
phosphorylation  	phosphorylation  	 NN	B-NP
of  	of  	 IN	I-NP
p53  	p53  	 NN	I-NP
by  	by  	 IN	O
DNA-PK 	DNA-PK 	 NNP	B-NP
,  	,  	 ,	O
in  	in  	 IN	O
vitro 	vitro 	 NN	B-NP
,  	,  	 ,	O
creates  	creates  	 VBZ	O
a  	a  	 DT	O
site  	site  	 NN	O
for  	for  	 IN	O
GSK3β  	GSK3β  	 CD	B-NP
to  	to  	 TO	O
phosphorylate  	phosphorylate  	 VB	O
p53 	p53 	 NN	B-NP
.  	.  	 .	O
Next 	Next 	 JJ	O
,  	,  	 ,	O
we  	we  	 PRP	O
set  	set  	 VBD	O
out  	out  	 RP	O
to  	to  	 TO	O
identify  	identify  	 VB	O
the  	the  	 DT	O
exact  	exact  	 JJ	B-NP
amino-acid 	amino-acid 	 NN	I-NP
( 	( 	 -LRB-	I-NP
s 	s 	 LS	I-NP
)  	)  	 -RRB-	I-NP
within  	within  	 IN	O
the  	the  	 DT	O
p53  	p53  	 NN	B-NP
protein  	protein  	 NN	I-NP
which  	which  	 WDT	O
were  	were  	 VBD	O
phosphorylated  	phosphorylated  	 VBN	O
by  	by  	 IN	O
GSK3β.  	GSK3β.  	 CD	B-NP
p53  	p53  	 NN	O
is  	is  	 VBZ	O
phosphorylated  	phosphorylated  	 VBN	O
by  	by  	 IN	O
DNA-PK  	DNA-PK  	 JJ	B-NP
at  	at  	 IN	O
serines  	serines  	 CD	B-NP
15  	15  	 CD	O
and  	and  	 CC	O
37  	37  	 CD	O
[  	[  	 -LRB-	O
32 	32 	 CD	O
] 	] 	 -RRB-	O
.  	.  	 .	O
Of  	Of  	 IN	O
these  	these  	 DT	O
2  	2  	 CD	O
sites 	sites 	 NNS	O
,  	,  	 ,	O
the  	the  	 DT	O
sequence  	sequence  	 NN	O
around  	around  	 IN	O
serine  	serine  	 CD	B-NP
37  	37  	 CD	O
contains  	contains  	 VBZ	O
a  	a  	 DT	O
predicted  	predicted  	 VBD	B-NP
GSK3  	GSK3  	 CD	I-NP
phosphorylation  	phosphorylation  	 JJ	I-NP
site  	site  	 NN	I-NP
at  	at  	 IN	O
serine  	serine  	 CD	B-NP
33  	33  	 CD	O
( 	( 	 -LRB-	O
figure  	figure  	 NN	O
2 	2 	 CD	O
,  	,  	 ,	O
underlined 	underlined 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Serine  	Serine  	 NNP	B-NP
33  	33  	 CD	O
and  	and  	 CC	O
37  	37  	 CD	O
of  	of  	 IN	O
p53  	p53  	 NN	B-NP
were  	were  	 VBD	O
individually  	individually  	 RB	O
mutated  	mutated  	 VBN	O
to  	to  	 TO	O
alanine 	alanine 	 VB	O
,  	,  	 ,	O
and  	and  	 CC	O
p53-GST  	p53-GST  	 CD	B-NP
fusion  	fusion  	 NN	I-NP
proteins  	proteins  	 NNS	I-NP
containing  	containing  	 VBG	O
these  	these  	 DT	O
mutations  	mutations  	 NN	O
prepared 	prepared 	 VBN	O
.  	.  	 .	O
The  	The  	 DT	O
ability  	ability  	 NN	B-NP
of  	of  	 IN	I-NP
DNA-PK  	DNA-PK  	 JJ	I-NP
to  	to  	 TO	O
create  	create  	 VB	O
a  	a  	 DT	O
GSK3β  	GSK3β  	 JJ	B-NP
phosphorylation  	phosphorylation  	 JJ	I-NP
site  	site  	 NN	I-NP
on  	on  	 IN	O
these  	these  	 DT	O
p53  	p53  	 NN	B-NP
proteins  	proteins  	 NNS	I-NP
was  	was  	 VBD	O
then  	then  	 RB	O
examined 	examined 	 VBN	O
.  	.  	 .	O
In  	In  	 IN	O
the  	the  	 DT	O
absence  	absence  	 NN	B-NP
of  	of  	 IN	I-NP
p53 	p53 	 NN	I-NP
,  	,  	 ,	O
no  	no  	 DT	O
phosphorylation  	phosphorylation  	 NN	B-NP
by  	by  	 IN	O
GSK3β  	GSK3β  	 NNP	B-NP
was  	was  	 VBD	O
detected  	detected  	 VBN	O
( 	( 	 -LRB-	O
fig  	fig  	 CD	O
2 	2 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Unphosphorylated  	Unphosphorylated  	 NNP	O
p53-GST  	p53-GST  	 NNP	B-NP
was  	was  	 VBD	O
not  	not  	 RB	O
a  	a  	 DT	O
substrate  	substrate  	 NN	O
for  	for  	 IN	O
GSK3β 	GSK3β 	 NNP	B-NP
,  	,  	 ,	O
whereas  	whereas  	 IN	O
p53-GST  	p53-GST  	 CD	B-NP
prephosphorylated  	prephosphorylated  	 NN	O
by  	by  	 IN	O
DNA-PK  	DNA-PK  	 NNP	B-NP
was  	was  	 VBD	O
( 	( 	 -LRB-	O
fig  	fig  	 CD	O
2 	2 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Mutation  	Mutation  	 NN	O
of  	of  	 IN	O
serine  	serine  	 CD	B-NP
33  	33  	 CD	O
of  	of  	 IN	O
p53  	p53  	 NN	B-NP
to  	to  	 TO	O
alanine  	alanine  	 VB	O
( 	( 	 -LRB-	O
S33A 	S33A 	 NNP	O
)  	)  	 -RRB-	O
blocked  	blocked  	 VBD	O
the  	the  	 DT	O
ability  	ability  	 NN	B-NP
of  	of  	 IN	I-NP
GSK3β  	GSK3β  	 CD	I-NP
to  	to  	 TO	O
phosphorylate  	phosphorylate  	 VB	O
p53 	p53 	 NN	B-NP
,  	,  	 ,	O
indicating  	indicating  	 VBG	O
that  	that  	 IN	O
serine  	serine  	 CD	B-NP
33  	33  	 CD	O
is  	is  	 VBZ	O
the  	the  	 DT	O
likely  	likely  	 JJ	O
target  	target  	 NN	O
for  	for  	 IN	O
GSK3β  	GSK3β  	 NNP	B-NP
( 	( 	 -LRB-	O
fig  	fig  	 CD	O
2 	2 	 CD	O
,  	,  	 ,	O
33 	33 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Similarly 	Similarly 	 RB	O
,  	,  	 ,	O
mutation  	mutation  	 NN	O
of  	of  	 IN	O
serine  	serine  	 CD	B-NP
37 	37 	 CD	O
,  	,  	 ,	O
which  	which  	 WDT	O
abolishes  	abolishes  	 VBZ	O
the  	the  	 DT	O
DNA-PK  	DNA-PK  	 JJ	B-NP
phosphorylation  	phosphorylation  	 JJ	I-NP
site 	site 	 NN	I-NP
,  	,  	 ,	O
blocks  	blocks  	 VBZ	O
phosphorylation  	phosphorylation  	 VBN	O
of  	of  	 IN	O
p53  	p53  	 NN	B-NP
by  	by  	 IN	O
GSK3β 	GSK3β 	 CD	B-NP
.  	.  	 .	O
This  	This  	 DT	O
indicates  	indicates  	 VBZ	O
that  	that  	 DT	O
p53  	p53  	 NN	B-NP
must  	must  	 MD	O
be  	be  	 VB	O
phosphorylated  	phosphorylated  	 VBN	O
on  	on  	 IN	O
serine  	serine  	 CD	B-NP
37  	37  	 CD	O
by  	by  	 IN	O
DNA-PK  	DNA-PK  	 JJ	B-NP
before  	before  	 IN	O
it  	it  	 PRP	O
can  	can  	 MD	O
be  	be  	 VB	O
phosphorylated  	phosphorylated  	 VBN	O
at  	at  	 IN	O
serine  	serine  	 CD	B-NP
33  	33  	 CD	O
by  	by  	 IN	O
GSK3β 	GSK3β 	 CD	B-NP
.  	.  	 .	O
To  	To  	 TO	O
examine  	examine  	 VB	O
the  	the  	 DT	O
in  	in  	 IN	O
vivo  	vivo  	 JJ	B-NP
function  	function  	 NN	I-NP
of  	of  	 IN	O
these  	these  	 DT	O
in  	in  	 IN	O
vitro  	vitro  	 JJ	B-NP
phosphorylations 	phosphorylations 	 NN	I-NP
,  	,  	 ,	O
wtp53  	wtp53  	 NNP	B-NP
and  	and  	 CC	O
p53  	p53  	 NN	B-NP
with  	with  	 IN	O
the  	the  	 DT	O
S33A  	S33A  	 NNP	O
and  	and  	 CC	O
S37A  	S37A  	 CD	O
mutations  	mutations  	 NNS	O
were  	were  	 VBD	O
sub-cloned  	sub-cloned  	 JJ	B-NP
into  	into  	 IN	O
the  	the  	 DT	O
expression  	expression  	 NN	B-NP
vector  	vector  	 NN	I-NP
pcDNA3.1 	pcDNA3.1 	 NN	I-NP
.  	.  	 .	O
These  	These  	 DT	O
were  	were  	 VBD	O
then  	then  	 RB	O
expressed  	expressed  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
human  	human  	 JJ	O
osteosarcoma  	osteosarcoma  	 JJ	B-NP
cell  	cell  	 NN	I-NP
line  	line  	 NN	I-NP
SAOS-2 	SAOS-2 	 NN	I-NP
,  	,  	 ,	O
which  	which  	 WDT	O
does  	does  	 VBZ	O
not  	not  	 RB	O
express  	express  	 VB	O
endogenous  	endogenous  	 JJ	B-NP
p53  	p53  	 NN	I-NP
protein  	protein  	 NN	I-NP
[  	[  	 -LRB-	O
33 	33 	 CD	O
] 	] 	 -RRB-	O
.  	.  	 .	O
First 	First 	 NNP	O
,  	,  	 ,	O
we  	we  	 PRP	O
analyzed  	analyzed  	 VBD	O
the  	the  	 DT	O
level  	level  	 NN	O
of  	of  	 IN	O
expression  	expression  	 NN	O
of  	of  	 IN	O
each  	each  	 DT	O
of  	of  	 IN	O
the  	the  	 DT	O
p53  	p53  	 NN	B-NP
proteins  	proteins  	 NNS	I-NP
following  	following  	 VBG	O
transient  	transient  	 JJ	O
expression  	expression  	 NN	O
in  	in  	 IN	O
SAOS-2  	SAOS-2  	 CD	B-NP
cells 	cells 	 NNS	I-NP
.  	.  	 .	O
In  	In  	 IN	O
fig  	fig  	 CD	O
3A 	3A 	 CD	O
,  	,  	 ,	O
approx  	approx  	 JJ	O
equal  	equal  	 JJ	O
amounts  	amounts  	 NNS	O
of  	of  	 IN	O
wtp53 	wtp53 	 NNP	B-NP
,  	,  	 ,	O
p53S33A  	p53S33A  	 NNP	O
and  	and  	 CC	O
p53S37A  	p53S37A  	 NNP	O
were  	were  	 VBD	O
detected  	detected  	 VBN	O
by  	by  	 IN	O
western  	western  	 JJ	O
blot 	blot 	 NN	O
,  	,  	 ,	O
indicating  	indicating  	 VBG	O
that  	that  	 IN	O
they  	they  	 PRP	O
were  	were  	 VBD	O
expressed  	expressed  	 VBN	O
at  	at  	 IN	O
similar  	similar  	 JJ	O
levels 	levels 	 NNS	O
.  	.  	 .	O
In  	In  	 IN	O
fig  	fig  	 CD	O
3B 	3B 	 CD	O
,  	,  	 ,	O
we  	we  	 PRP	O
examined  	examined  	 VBD	O
the  	the  	 DT	O
transcriptional  	transcriptional  	 JJ	B-NP
activity  	activity  	 NN	I-NP
of  	of  	 IN	O
these  	these  	 DT	O
p53  	p53  	 NN	B-NP
constructs 	constructs 	 NN	O
.  	.  	 .	O
A  	A  	 DT	O
p53-reporter  	p53-reporter  	 JJ	B-NP
construct 	construct 	 NN	O
,  	,  	 ,	O
p50-2 	p50-2 	 NNP	B-NP
,  	,  	 ,	O
which  	which  	 WDT	O
specifically  	specifically  	 RB	O
responds  	responds  	 VBZ	O
to  	to  	 TO	O
wtp53  	wtp53  	 CD	B-NP
by  	by  	 IN	O
increasing  	increasing  	 VBG	B-NP
transcription  	transcription  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
luciferase  	luciferase  	 JJ	I-NP
gene 	gene 	 NN	I-NP
,  	,  	 ,	O
was  	was  	 VBD	O
used  	used  	 VBN	O
[ 	[ 	 -LRB-	O
described  	described  	 VBN	O
in  	in  	 IN	O
33 	33 	 CD	O
] 	] 	 -RRB-	O
.  	.  	 .	O
In  	In  	 IN	O
fig  	fig  	 CD	O
3B 	3B 	 CD	O
,  	,  	 ,	O
SAOS-2  	SAOS-2  	 FW	B-NP
cells  	cells  	 FW	I-NP
transiently  	transiently  	 FW	O
expressing  	expressing  	 FW	B-NP
vector  	vector  	 FW	I-NP
( 	( 	 -LRB-	O
Con 	Con 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
showed  	showed  	 VBD	O
minimal  	minimal  	 JJ	O
activation  	activation  	 NN	B-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
p53-reporter  	p53-reporter  	 JJ	I-NP
construct 	construct 	 NN	O
.  	.  	 .	O
Cells  	Cells  	 NNS	O
expressing  	expressing  	 VBG	B-NP
wtp53  	wtp53  	 NNP	I-NP
showed  	showed  	 VBD	O
significant  	significant  	 JJ	O
activation 	activation 	 NN	B-NP
,  	,  	 ,	O
as  	as  	 RB	O
did  	did  	 VBD	O
cells  	cells  	 NNS	O
expressing  	expressing  	 VBG	O
both  	both  	 PDT	O
the  	the  	 DT	O
S33A  	S33A  	 NNP	O
and  	and  	 CC	O
S37A  	S37A  	 CD	O
mutations 	mutations 	 NNS	O
.  	.  	 .	O
Both  	Both  	 PDT	O
the  	the  	 DT	O
S33A  	S33A  	 NNP	O
and  	and  	 CC	O
S37A  	S37A  	 CD	O
mutations  	mutations  	 NNS	O
displayed  	displayed  	 VBD	O
slightly  	slightly  	 RB	O
higher  	higher  	 RBR	O
basal  	basal  	 JJ	B-NP
levels  	levels  	 NNS	I-NP
of  	of  	 IN	I-NP
transcriptional  	transcriptional  	 JJ	I-NP
activity  	activity  	 NN	I-NP
than  	than  	 IN	O
the  	the  	 DT	O
wtp53  	wtp53  	 JJ	B-NP
protein 	protein 	 NN	I-NP
.  	.  	 .	O
Serines  	Serines  	 NNP	B-NP
33  	33  	 CD	O
and  	and  	 CC	O
37  	37  	 CD	O
are  	are  	 VBP	O
located  	located  	 VBN	O
within  	within  	 IN	O
the  	the  	 DT	O
N-terminal  	N-terminal  	 JJ	B-NP
transcriptional  	transcriptional  	 JJ	I-NP
activation  	activation  	 JJ	I-NP
domain  	domain  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
p53  	p53  	 NN	I-NP
protein 	protein 	 NN	I-NP
.  	.  	 .	O
To  	To  	 TO	O
determine  	determine  	 VB	O
if  	if  	 IN	O
GSK3β  	GSK3β  	 NNP	B-NP
regulates  	regulates  	 VBZ	O
p53 	p53 	 NN	O
's  	's  	 POS	O
transcriptional  	transcriptional  	 JJ	B-NP
activity  	activity  	 NN	I-NP
in  	in  	 IN	O
vivo 	vivo 	 NN	B-NP
,  	,  	 ,	O
a  	a  	 DT	O
wild  	wild  	 JJ	O
type  	type  	 NN	B-NP
GSK3β  	GSK3β  	 CD	I-NP
expression  	expression  	 NN	I-NP
vector  	vector  	 NN	I-NP
was  	was  	 VBD	O
cotransfected  	cotransfected  	 VBN	O
with  	with  	 IN	O
either  	either  	 DT	O
wtp53  	wtp53  	 NNP	B-NP
or  	or  	 CC	O
p53  	p53  	 NN	B-NP
with  	with  	 IN	O
mutations  	mutations  	 NNS	O
in  	in  	 IN	O
serines  	serines  	 CD	B-NP
33  	33  	 CD	O
or  	or  	 CC	O
37 	37 	 CD	O
.  	.  	 .	O
The  	The  	 DT	O
ability  	ability  	 NN	B-NP
of  	of  	 IN	I-NP
GSK3β  	GSK3β  	 CD	I-NP
to  	to  	 TO	O
activate  	activate  	 VB	O
each  	each  	 DT	O
construct  	construct  	 NN	O
was  	was  	 VBD	O
calculated  	calculated  	 VBN	O
by  	by  	 IN	O
expressing  	expressing  	 VBG	O
the  	the  	 DT	O
p53  	p53  	 NN	B-NP
transcriptional  	transcriptional  	 NN	I-NP
activity  	activity  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
presence  	presence  	 NN	O
of  	of  	 IN	O
GSK3β  	GSK3β  	 CD	B-NP
as  	as  	 IN	O
a  	a  	 DT	O
percentage  	percentage  	 NN	O
of  	of  	 IN	O
that  	that  	 WDT	O
observed  	observed  	 VBD	O
in  	in  	 IN	O
the  	the  	 DT	O
absence  	absence  	 NN	B-NP
of  	of  	 IN	I-NP
GSK3β 	GSK3β 	 CD	I-NP
.  	.  	 .	O
On  	On  	 IN	O
this  	this  	 DT	O
scale 	scale 	 NN	O
,  	,  	 ,	O
no  	no  	 DT	O
activation  	activation  	 NN	B-NP
by  	by  	 IN	O
GSK3β  	GSK3β  	 CD	B-NP
yields  	yields  	 NNS	I-NP
a  	a  	 DT	O
zero  	zero  	 CD	O
percent  	percent  	 NN	O
increase  	increase  	 NN	O
in  	in  	 IN	O
p53  	p53  	 NN	B-NP
transcriptional  	transcriptional  	 VBZ	O
relative  	relative  	 JJ	O
to  	to  	 TO	O
p53  	p53  	 NN	B-NP
alone 	alone 	 RB	O
.  	.  	 .	O
GSK3β  	GSK3β  	 NNP	B-NP
alone  	alone  	 RB	O
( 	( 	 -LRB-	O
fig  	fig  	 FW	O
3C 	3C 	 FW	O
,  	,  	 ,	O
Con 	Con 	 NNP	O
)  	)  	 -RRB-	O
did  	did  	 VBD	O
not  	not  	 RB	O
significantly  	significantly  	 RB	O
increase  	increase  	 VB	O
the  	the  	 DT	O
activity  	activity  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
luciferase  	luciferase  	 JJ	B-NP
reporter  	reporter  	 NN	I-NP
construct 	construct 	 NN	O
.  	.  	 .	O
When  	When  	 WRB	O
GSK3β  	GSK3β  	 NNP	B-NP
was  	was  	 VBD	O
cotransfected  	cotransfected  	 VBN	O
with  	with  	 IN	O
wtp53 	wtp53 	 NNP	B-NP
,  	,  	 ,	O
p53-dependent  	p53-dependent  	 CD	B-NP
activity  	activity  	 NN	I-NP
from  	from  	 IN	O
the  	the  	 DT	O
luciferase  	luciferase  	 JJ	B-NP
reporter  	reporter  	 NN	I-NP
construct  	construct  	 NNS	O
was  	was  	 VBD	O
increased  	increased  	 VBN	O
by  	by  	 IN	O
160 	160 	 CD	O
%  	%  	 NN	O
compared  	compared  	 VBN	O
to  	to  	 TO	O
wtp53  	wtp53  	 CD	B-NP
alone 	alone 	 RB	O
.  	.  	 .	O
To  	To  	 TO	O
determine  	determine  	 VB	O
if  	if  	 IN	O
this  	this  	 DT	O
activation  	activation  	 NN	B-NP
of  	of  	 IN	I-NP
p53  	p53  	 NN	I-NP
transcriptional  	transcriptional  	 NN	I-NP
activity  	activity  	 NN	I-NP
required  	required  	 VBD	O
the  	the  	 DT	O
GSK3β  	GSK3β  	 JJ	B-NP
phosphorylation  	phosphorylation  	 JJ	I-NP
site  	site  	 NN	I-NP
at  	at  	 IN	O
serine  	serine  	 CD	B-NP
33 	33 	 CD	O
,  	,  	 ,	O
wtp53  	wtp53  	 NNP	B-NP
with  	with  	 IN	O
serine  	serine  	 VBG	O
to  	to  	 TO	O
alanine  	alanine  	 VB	O
mutations  	mutations  	 VBN	O
at  	at  	 IN	O
either  	either  	 DT	O
positions  	positions  	 NNS	O
33  	33  	 CD	O
or  	or  	 CC	O
37  	37  	 CD	O
were  	were  	 VBD	O
cotransfected  	cotransfected  	 VBN	O
with  	with  	 IN	O
GSK3β 	GSK3β 	 CD	B-NP
.  	.  	 .	O
Mutation  	Mutation  	 NN	O
of  	of  	 IN	O
either  	either  	 DT	O
serine  	serine  	 JJ	O
33  	33  	 CD	O
or  	or  	 CC	O
37  	37  	 CD	O
significantly  	significantly  	 RB	O
reduced  	reduced  	 VBN	O
the  	the  	 DT	O
ability  	ability  	 NN	B-NP
of  	of  	 IN	I-NP
GSK3β  	GSK3β  	 CD	I-NP
to  	to  	 TO	O
upregulate  	upregulate  	 VB	O
p53  	p53  	 NN	B-NP
transcriptional  	transcriptional  	 NN	I-NP
activity 	activity 	 NN	I-NP
.  	.  	 .	O
This  	This  	 DT	O
is  	is  	 VBZ	O
consistent  	consistent  	 JJ	O
with  	with  	 IN	O
the  	the  	 DT	O
phosphorylation  	phosphorylation  	 JJ	B-NP
data  	data  	 NNS	I-NP
in  	in  	 IN	O
fig  	fig  	 CD	O
1and  	1and  	 CD	O
2 	2 	 CD	O
,  	,  	 ,	O
which  	which  	 WDT	O
indicated  	indicated  	 VBD	O
that  	that  	 IN	O
serine  	serine  	 CD	B-NP
37  	37  	 CD	O
phosphorylation  	phosphorylation  	 NN	B-NP
is  	is  	 VBZ	O
required  	required  	 VBN	O
for  	for  	 IN	O
the  	the  	 DT	O
subsequent  	subsequent  	 JJ	O
phosphorylation  	phosphorylation  	 NN	B-NP
of  	of  	 IN	I-NP
serine  	serine  	 CD	I-NP
33  	33  	 CD	O
by  	by  	 IN	O
GSK3β 	GSK3β 	 CD	B-NP
.  	.  	 .	O
These  	These  	 DT	O
results  	results  	 NNS	O
suggests  	suggests  	 VBZ	O
that  	that  	 IN	O
GSK3β  	GSK3β  	 NNP	B-NP
may  	may  	 MD	O
be  	be  	 VB	O
a  	a  	 DT	O
physiological  	physiological  	 JJ	B-NP
regulator  	regulator  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
p53  	p53  	 NN	I-NP
protein 	protein 	 NN	I-NP
.  	.  	 .	O
GSK3β  	GSK3β  	 NNP	B-NP
is  	is  	 VBZ	O
constitutively  	constitutively  	 JJ	O
active  	active  	 JJ	O
in  	in  	 IN	O
resting  	resting  	 JJ	O
cells 	cells 	 NNS	O
,  	,  	 ,	O
and  	and  	 CC	O
is  	is  	 VBZ	O
inactivated  	inactivated  	 VBN	O
by  	by  	 IN	O
PKB  	PKB  	 NNP	B-NP
through  	through  	 IN	O
the  	the  	 DT	O
growth  	growth  	 NN	O
factor  	factor  	 NN	O
dependent  	dependent  	 FW	O
p110-PI  	p110-PI  	 FW	O
3-kinase  	3-kinase  	 FW	O
pathway  	pathway  	 FW	O
[  	[  	 -LRB-	O
25 	25 	 CD	O
,  	,  	 ,	O
28 	28 	 CD	O
,  	,  	 ,	O
29 	29 	 CD	O
] 	] 	 -RRB-	O
.  	.  	 .	O
Thus  	Thus  	 RB	O
the  	the  	 DT	O
activity  	activity  	 NN	O
of  	of  	 IN	O
GSK3β  	GSK3β  	 CD	B-NP
in  	in  	 IN	O
growing  	growing  	 VBG	O
cells  	cells  	 NNS	O
is  	is  	 VBZ	O
less  	less  	 JJR	O
than  	than  	 IN	O
that  	that  	 DT	O
in  	in  	 IN	O
cells  	cells  	 NNS	O
arrested  	arrested  	 VBN	O
in  	in  	 IN	O
Go.  	Go.  	 CD	O
p53  	p53  	 NN	B-NP
can  	can  	 MD	O
be  	be  	 VB	O
activated  	activated  	 VBN	O
by  	by  	 IN	O
several  	several  	 JJ	O
distinct  	distinct  	 JJ	O
pathways 	pathways 	 NN	O
,  	,  	 ,	O
including  	including  	 VBG	B-NP
DNA  	DNA  	 NN	I-NP
damage 	damage 	 NN	I-NP
.  	.  	 .	O
If  	If  	 IN	O
GSK3β  	GSK3β  	 NNP	B-NP
is  	is  	 VBZ	O
involved  	involved  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
activation  	activation  	 NN	B-NP
of  	of  	 IN	I-NP
p53  	p53  	 NN	I-NP
by  	by  	 IN	O
DNA  	DNA  	 NNP	B-NP
damage 	damage 	 NN	I-NP
,  	,  	 ,	O
then  	then  	 RB	O
GSK3β  	GSK3β  	 RB	O
is  	is  	 VBZ	O
predicted  	predicted  	 VBN	O
to  	to  	 TO	O
be  	be  	 VB	O
upregulated  	upregulated  	 VBN	O
in  	in  	 IN	O
response  	response  	 NN	O
to  	to  	 TO	O
DNA  	DNA  	 NNP	B-NP
damage 	damage 	 NN	I-NP
.  	.  	 .	O
In  	In  	 IN	O
fig  	fig  	 CD	O
4 	4 	 CD	O
,  	,  	 ,	O
GSK3β  	GSK3β  	 CD	B-NP
kinase  	kinase  	 JJ	I-NP
activity  	activity  	 NN	I-NP
was  	was  	 VBD	O
monitored  	monitored  	 VBN	O
by  	by  	 IN	O
immunoprecipitating  	immunoprecipitating  	 JJ	B-NP
GSK3β  	GSK3β  	 NN	I-NP
and  	and  	 CC	O
then  	then  	 RB	O
measuring  	measuring  	 VBG	O
the  	the  	 DT	O
ability  	ability  	 NN	B-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
immunoprecipitated  	immunoprecipitated  	 JJ	I-NP
protein  	protein  	 NN	I-NP
to  	to  	 TO	O
phosphorylate  	phosphorylate  	 VB	O
a  	a  	 DT	O
specific  	specific  	 JJ	O
GSK3β  	GSK3β  	 FW	B-NP
peptide  	peptide  	 FW	I-NP
substrate 	substrate 	 FW	I-NP
.  	.  	 .	O
In  	In  	 IN	O
fig  	fig  	 CD	O
4 	4 	 CD	O
,  	,  	 ,	O
the  	the  	 DT	O
omission  	omission  	 NN	O
of  	of  	 IN	O
either  	either  	 RB	O
the  	the  	 DT	O
peptide  	peptide  	 NN	B-NP
or  	or  	 CC	O
the  	the  	 DT	O
GSK3β  	GSK3β  	 JJ	B-NP
antibody  	antibody  	 NN	I-NP
from  	from  	 IN	O
the  	the  	 DT	O
assay  	assay  	 NN	B-NP
resulted  	resulted  	 VBD	O
in  	in  	 IN	O
minimal  	minimal  	 JJ	O
phosphorylation  	phosphorylation  	 NN	B-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
substrate  	substrate  	 JJ	I-NP
peptide  	peptide  	 NNS	I-NP
( 	( 	 -LRB-	O
fig  	fig  	 CD	O
4 	4 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
When  	When  	 WRB	O
both  	both  	 DT	O
GSK3β  	GSK3β  	 JJ	B-NP
antibody  	antibody  	 NN	I-NP
and  	and  	 CC	O
substrate  	substrate  	 JJ	B-NP
peptide  	peptide  	 NN	I-NP
were  	were  	 VBD	O
employed 	employed 	 VBN	O
,  	,  	 ,	O
high  	high  	 JJ	O
levels  	levels  	 NNS	O
of  	of  	 IN	O
GSK3β-dependent  	GSK3β-dependent  	 CD	B-NP
kinase  	kinase  	 JJ	I-NP
activity  	activity  	 NN	I-NP
were  	were  	 VBD	O
detected 	detected 	 VBN	O
.  	.  	 .	O
When  	When  	 WRB	O
cells  	cells  	 NNS	O
were  	were  	 VBD	O
incubated  	incubated  	 VBN	O
for  	for  	 IN	O
24  	24  	 CD	O
h  	h  	 NN	O
in  	in  	 IN	O
low  	low  	 JJ	O
serum  	serum  	 NNS	B-NP
( 	( 	 -LRB-	O
0.5 	0.5 	 CD	O
% 	% 	 NN	O
)  	)  	 -RRB-	O
to  	to  	 TO	O
induce  	induce  	 VB	O
growth  	growth  	 NN	B-NP
arrest  	arrest  	 NN	I-NP
in  	in  	 IN	O
Go 	Go 	 NNP	O
,  	,  	 ,	O
the  	the  	 DT	O
levels  	levels  	 NNS	O
of  	of  	 IN	O
GSK3β  	GSK3β  	 CD	B-NP
activity  	activity  	 NN	I-NP
were  	were  	 VBD	O
increased  	increased  	 VBN	O
compared  	compared  	 VBN	O
to  	to  	 TO	O
asynchronously  	asynchronously  	 VB	O
growing  	growing  	 VBG	O
cells  	cells  	 NNS	O
( 	( 	 -LRB-	O
fig  	fig  	 CD	O
4 	4 	 CD	O
,  	,  	 ,	O
Go 	Go 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
When  	When  	 WRB	O
asynchronously  	asynchronously  	 NNS	O
growing  	growing  	 VBG	O
cells  	cells  	 NNS	O
were  	were  	 VBD	O
exposed  	exposed  	 VBN	O
to  	to  	 TO	O
5Gy  	5Gy  	 CD	B-NP
or  	or  	 CC	O
10Gy  	10Gy  	 CD	O
of  	of  	 IN	O
Ionizing  	Ionizing  	 NNP	B-NP
Radiation  	Radiation  	 NNP	I-NP
to  	to  	 TO	O
cause  	cause  	 VB	O
DNA  	DNA  	 NN	B-NP
damage 	damage 	 NN	I-NP
,  	,  	 ,	O
the  	the  	 DT	O
levels  	levels  	 NNS	O
of  	of  	 IN	O
GSK3β  	GSK3β  	 CD	B-NP
activity  	activity  	 NN	I-NP
were  	were  	 VBD	O
reduced 	reduced 	 VBN	O
.  	.  	 .	O
Similar  	Similar  	 JJ	B-NP
results  	results  	 NNS	I-NP
were  	were  	 VBD	O
seen  	seen  	 VBN	O
using  	using  	 VBG	O
p53-GST  	p53-GST  	 NN	B-NP
as  	as  	 IN	O
the  	the  	 DT	O
substrate  	substrate  	 NN	O
for  	for  	 IN	O
GSK3β  	GSK3β  	 CD	B-NP
phosphorylation  	phosphorylation  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
kinase  	kinase  	 JJ	B-NP
assay  	assay  	 NNS	I-NP
( 	( 	 -LRB-	O
data  	data  	 NNS	O
not  	not  	 RB	O
shown 	shown 	 VBN	O
) 	) 	 -RRB-	O
.  	.  	 .	O
This  	This  	 DT	O
implies  	implies  	 NN	O
that  	that  	 IN	O
the  	the  	 DT	O
phosphorylation  	phosphorylation  	 NN	B-NP
of  	of  	 IN	I-NP
serine  	serine  	 CD	I-NP
33  	33  	 CD	O
of  	of  	 IN	O
p53  	p53  	 NN	B-NP
by  	by  	 IN	O
GSK3β  	GSK3β  	 NNP	B-NP
would  	would  	 MD	O
be  	be  	 VB	O
decreased  	decreased  	 VBN	O
in  	in  	 IN	O
cells  	cells  	 NNS	O
exposed  	exposed  	 VBN	O
to  	to  	 TO	O
DNA  	DNA  	 NNP	B-NP
damage 	damage 	 NN	I-NP
,  	,  	 ,	O
but  	but  	 CC	O
elevated  	elevated  	 VBD	O
in  	in  	 IN	O
cells  	cells  	 NNS	B-NP
growth  	growth  	 NN	I-NP
arrested  	arrested  	 VBN	O
in  	in  	 IN	O
Go 	Go 	 NNP	O
.  	.  	 .	O
Discussion  	Discussion  	 NN	O
Several  	Several  	 JJ	O
p53  	p53  	 NN	B-NP
kinases  	kinases  	 NNS	I-NP
were  	were  	 VBD	O
examined  	examined  	 VBN	O
for  	for  	 IN	O
their  	their  	 PRP$	O
ability  	ability  	 NN	B-NP
to  	to  	 TO	O
create  	create  	 VB	O
in  	in  	 IN	O
vitro  	vitro  	 CD	B-NP
GSK3  	GSK3  	 CD	I-NP
phosphorylation  	phosphorylation  	 CD	I-NP
sites  	sites  	 NNS	I-NP
on  	on  	 IN	O
p53 	p53 	 NN	B-NP
.  	.  	 .	O
Phosphorylation  	Phosphorylation  	 NNP	B-NP
of  	of  	 IN	I-NP
p53  	p53  	 NN	I-NP
by  	by  	 IN	O
DNA-PK  	DNA-PK  	 NNP	B-NP
created  	created  	 VBD	O
a  	a  	 DT	O
phosphorylation  	phosphorylation  	 JJ	B-NP
site  	site  	 NN	I-NP
for  	for  	 IN	I-NP
GSK3β 	GSK3β 	 NNP	I-NP
,  	,  	 ,	O
but  	but  	 CC	O
not  	not  	 RB	O
for  	for  	 IN	O
GSK3α 	GSK3α 	 CD	B-NP
.  	.  	 .	O
GSK3α  	GSK3α  	 NNP	B-NP
and  	and  	 CC	O
GSK3β  	GSK3β  	 RB	O
have  	have  	 VB	O
98 	98 	 CD	O
%  	%  	 NN	O
homology  	homology  	 NN	B-NP
within  	within  	 IN	O
the  	the  	 DT	O
kinase  	kinase  	 JJ	B-NP
domain 	domain 	 NN	I-NP
,  	,  	 ,	O
although  	although  	 IN	O
regions  	regions  	 NNS	O
N-  	N-  	 JJ	O
and  	and  	 CC	O
C-terminal  	C-terminal  	 JJ	B-NP
to  	to  	 TO	O
this  	this  	 DT	O
are  	are  	 VBP	O
less  	less  	 RBR	O
well  	well  	 RB	O
conserved  	conserved  	 JJ	O
[  	[  	 -LRB-	O
36 	36 	 CD	O
] 	] 	 -RRB-	O
.  	.  	 .	O
GSK3α  	GSK3α  	 NNP	B-NP
and  	and  	 CC	O
GSK3β  	GSK3β  	 NNP	B-NP
have  	have  	 VBP	O
similar  	similar  	 JJ	O
substrate  	substrate  	 JJ	B-NP
specificity  	specificity  	 NN	I-NP
in  	in  	 IN	O
vivo 	vivo 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
are  	are  	 VBP	O
regulated  	regulated  	 VBN	O
in  	in  	 IN	O
parallel  	parallel  	 NN	B-NP
in  	in  	 IN	O
response  	response  	 NN	O
to  	to  	 TO	O
growth  	growth  	 NN	B-NP
factors  	factors  	 NNS	I-NP
[  	[  	 -LRB-	O
24 	24 	 CD	O
,  	,  	 ,	O
27 	27 	 CD	O
,  	,  	 ,	O
28 	28 	 CD	O
,  	,  	 ,	O
29 	29 	 CD	O
] 	] 	 -RRB-	O
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
disruption  	disruption  	 NN	O
of  	of  	 IN	O
GSK3β  	GSK3β  	 CD	B-NP
in  	in  	 IN	O
mice  	mice  	 JJ	O
results  	results  	 NNS	O
in  	in  	 IN	O
embryonic  	embryonic  	 JJ	B-NP
lethality  	lethality  	 NN	I-NP
and  	and  	 CC	O
impaired  	impaired  	 JJ	O
NFκ  	NFκ  	 JJ	B-NP
B  	B  	 NN	I-NP
function  	function  	 NN	I-NP
[  	[  	 -LRB-	O
37 	37 	 CD	O
] 	] 	 -RRB-	O
,  	,  	 ,	O
indicating  	indicating  	 VBG	O
that  	that  	 IN	O
GSK3α  	GSK3α  	 CD	B-NP
cannot  	cannot  	 JJ	O
substitute  	substitute  	 NN	O
for  	for  	 IN	O
GSK3β  	GSK3β  	 CD	B-NP
in  	in  	 IN	O
this  	this  	 DT	O
model  	model  	 NN	B-NP
system 	system 	 NN	I-NP
.  	.  	 .	O
GSK3α  	GSK3α  	 NNP	B-NP
and  	and  	 CC	O
GSK3β  	GSK3β  	 NNP	B-NP
therefore  	therefore  	 RB	O
have  	have  	 VBP	O
overlapping  	overlapping  	 VBG	O
cellular  	cellular  	 JJ	B-NP
functions 	functions 	 NNS	I-NP
,  	,  	 ,	O
but  	but  	 CC	O
each  	each  	 DT	O
isoform  	isoform  	 NN	B-NP
also  	also  	 RB	O
regulates  	regulates  	 VBZ	O
distinct  	distinct  	 JJ	O
signaling  	signaling  	 JJ	O
pathways 	pathways 	 NN	O
.  	.  	 .	O
Our  	Our  	 PRP$	O
results  	results  	 NNS	O
clearly  	clearly  	 RB	O
show  	show  	 VB	O
that  	that  	 DT	O
p53  	p53  	 NN	B-NP
phsophorylation  	phsophorylation  	 NN	I-NP
is  	is  	 VBZ	O
specific  	specific  	 JJ	O
for  	for  	 IN	O
GSK3β 	GSK3β 	 CD	B-NP
.  	.  	 .	O
The  	The  	 DT	O
GSK3β  	GSK3β  	 JJ	B-NP
phosphorylation  	phosphorylation  	 JJ	I-NP
site  	site  	 NN	I-NP
was  	was  	 VBD	O
identified  	identified  	 VBN	O
by  	by  	 IN	O
mutagenesis  	mutagenesis  	 NN	B-NP
as  	as  	 IN	O
serine  	serine  	 CD	B-NP
33  	33  	 CD	O
of  	of  	 IN	O
p53 	p53 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
we  	we  	 PRP	O
were  	were  	 VBD	O
able  	able  	 JJ	O
to  	to  	 TO	O
show  	show  	 VB	O
that  	that  	 IN	O
this  	this  	 DT	O
was  	was  	 VBD	O
dependent  	dependent  	 JJ	O
on  	on  	 IN	O
prior  	prior  	 JJ	O
phosphorylation  	phosphorylation  	 NN	B-NP
of  	of  	 IN	I-NP
serine  	serine  	 CD	I-NP
37  	37  	 CD	O
by  	by  	 IN	O
DNA-PK 	DNA-PK 	 JJ	B-NP
.  	.  	 .	O
We  	We  	 PRP	O
also  	also  	 RB	O
examined  	examined  	 VBN	O
if  	if  	 IN	O
GSK3β  	GSK3β  	 NNP	B-NP
regulates  	regulates  	 VBZ	O
in  	in  	 IN	O
vivo  	vivo  	 JJ	B-NP
p53  	p53  	 NN	I-NP
function  	function  	 NN	I-NP
through  	through  	 IN	O
a  	a  	 DT	O
mechanism  	mechanism  	 NN	O
involving  	involving  	 VBG	B-NP
serines  	serines  	 CD	I-NP
33  	33  	 CD	O
and  	and  	 CC	O
37  	37  	 CD	O
of  	of  	 IN	O
p53 	p53 	 NN	B-NP
.  	.  	 .	O
Previous  	Previous  	 JJ	B-NP
studies  	studies  	 NNS	I-NP
have  	have  	 VBP	O
shown  	shown  	 VBN	O
that  	that  	 IN	O
phosphorylation  	phosphorylation  	 NN	B-NP
of  	of  	 IN	I-NP
serines  	serines  	 CD	I-NP
15 	15 	 CD	O
,  	,  	 ,	O
20 	20 	 CD	O
,  	,  	 ,	O
33  	33  	 CD	O
and  	and  	 CC	O
37  	37  	 CD	O
of  	of  	 IN	O
p53  	p53  	 NN	B-NP
block  	block  	 VB	O
the  	the  	 DT	O
interaction  	interaction  	 NN	O
of  	of  	 IN	O
p53  	p53  	 NN	B-NP
with  	with  	 IN	O
mdm2 	mdm2 	 NNP	B-NP
,  	,  	 ,	O
leading  	leading  	 VBG	O
to  	to  	 TO	O
stabilization  	stabilization  	 VB	B-NP
and  	and  	 CC	O
accumulation  	accumulation  	 NN	B-NP
of  	of  	 IN	I-NP
p53  	p53  	 NN	I-NP
protein  	protein  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
cell  	cell  	 NN	O
[  	[  	 -LRB-	O
10 	10 	 CD	O
,  	,  	 ,	O
11 	11 	 CD	O
,  	,  	 ,	O
13 	13 	 CD	O
,  	,  	 ,	O
14 	14 	 CD	O
,  	,  	 ,	O
15 	15 	 CD	O
,  	,  	 ,	O
18 	18 	 CD	O
] 	] 	 -RRB-	O
.  	.  	 .	O
mdm2  	mdm2  	 FW	B-NP
binding  	binding  	 FW	O
is  	is  	 VBZ	O
dependent  	dependent  	 JJ	O
on  	on  	 IN	O
the  	the  	 DT	O
phosphorylation  	phosphorylation  	 JJ	B-NP
status  	status  	 NN	I-NP
of  	of  	 IN	I-NP
serine  	serine  	 CD	I-NP
20  	20  	 CD	O
of  	of  	 IN	O
p53  	p53  	 NN	B-NP
[  	[  	 -LRB-	O
15 	15 	 CD	O
] 	] 	 -RRB-	O
,  	,  	 ,	O
although  	although  	 IN	O
phosphorylation  	phosphorylation  	 NN	B-NP
of  	of  	 IN	I-NP
serines  	serines  	 CD	I-NP
15 	15 	 CD	O
,  	,  	 ,	O
33  	33  	 CD	O
and  	and  	 CC	O
37  	37  	 CD	O
also  	also  	 RB	O
play  	play  	 VB	O
a  	a  	 DT	O
role 	role 	 NN	O
.  	.  	 .	O
We  	We  	 PRP	O
did  	did  	 VBD	O
not  	not  	 RB	O
detect  	detect  	 VB	O
any  	any  	 DT	O
significant  	significant  	 JJ	O
difference  	difference  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
level  	level  	 NN	O
of  	of  	 IN	O
expression  	expression  	 NN	O
of  	of  	 IN	O
p53  	p53  	 NN	B-NP
with  	with  	 IN	O
single  	single  	 JJ	O
mutations  	mutations  	 NNS	O
in  	in  	 IN	O
either  	either  	 DT	O
serines  	serines  	 JJ	O
33  	33  	 CD	O
or  	or  	 CC	O
37  	37  	 CD	O
when  	when  	 WRB	O
compared  	compared  	 VBN	O
to  	to  	 TO	O
wtp53 	wtp53 	 CD	B-NP
,  	,  	 ,	O
indicating  	indicating  	 VBG	O
that  	that  	 IN	O
single  	single  	 JJ	O
point  	point  	 NN	B-NP
mutations  	mutations  	 NNS	I-NP
in  	in  	 IN	O
serines  	serines  	 CD	B-NP
33  	33  	 CD	O
or  	or  	 CC	O
37  	37  	 CD	O
do  	do  	 VBP	O
not  	not  	 RB	O
greatly  	greatly  	 RB	O
alter  	alter  	 VB	O
p53  	p53  	 NN	B-NP
stability 	stability 	 NN	I-NP
.  	.  	 .	O
A  	A  	 DT	O
key  	key  	 JJ	B-NP
function  	function  	 NN	I-NP
of  	of  	 IN	I-NP
p53  	p53  	 NN	I-NP
is  	is  	 VBZ	O
the  	the  	 DT	O
transcriptional  	transcriptional  	 JJ	B-NP
activation  	activation  	 NN	I-NP
of  	of  	 IN	O
genes  	genes  	 NNS	O
which  	which  	 WDT	O
regulate  	regulate  	 JJ	O
growth  	growth  	 NN	B-NP
arrest  	arrest  	 NN	I-NP
and  	and  	 CC	O
apoptosis  	apoptosis  	 NNS	B-NP
[  	[  	 -LRB-	O
1 	1 	 CD	O
,  	,  	 ,	O
2 	2 	 CD	O
,  	,  	 ,	O
3 	3 	 CD	O
,  	,  	 ,	O
4 	4 	 LS	O
] 	] 	 -RRB-	O
.  	.  	 .	O
Individual  	Individual  	 JJ	B-NP
mutation  	mutation  	 NN	I-NP
of  	of  	 IN	O
either  	either  	 DT	O
serine  	serine  	 JJ	O
33  	33  	 CD	O
or  	or  	 CC	O
37  	37  	 CD	O
slightly  	slightly  	 RB	O
increased  	increased  	 VBD	O
the  	the  	 DT	O
basal  	basal  	 JJ	B-NP
transcriptional  	transcriptional  	 JJ	I-NP
activity  	activity  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
p53  	p53  	 NN	I-NP
protein 	protein 	 NN	I-NP
.  	.  	 .	O
This  	This  	 DT	O
is  	is  	 VBZ	O
in  	in  	 IN	O
keeping  	keeping  	 VBG	O
with  	with  	 IN	O
observations  	observations  	 NNS	B-NP
made  	made  	 VBN	O
by  	by  	 IN	O
other  	other  	 JJ	O
groups 	groups 	 NNS	O
,  	,  	 ,	O
who  	who  	 WP	O
demonstrated  	demonstrated  	 VBD	O
that  	that  	 DT	O
single  	single  	 JJ	O
or  	or  	 CC	O
multiple  	multiple  	 JJ	O
mutations  	mutations  	 NNS	O
in  	in  	 IN	O
p53  	p53  	 NN	B-NP
phosphorylation  	phosphorylation  	 NN	I-NP
sites  	sites  	 NNS	I-NP
has  	has  	 VBZ	O
minimal  	minimal  	 JJ	O
effect  	effect  	 NN	O
on  	on  	 IN	O
the  	the  	 DT	O
basal  	basal  	 JJ	B-NP
transcriptional  	transcriptional  	 JJ	I-NP
activity  	activity  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
p53  	p53  	 NN	I-NP
protein  	protein  	 NN	I-NP
[  	[  	 -LRB-	O
38 	38 	 CD	O
,  	,  	 ,	O
39 	39 	 CD	O
,  	,  	 ,	O
40 	40 	 CD	O
] 	] 	 -RRB-	O
.  	.  	 .	O
We  	We  	 PRP	O
also  	also  	 RB	O
determined  	determined  	 VBN	O
if  	if  	 IN	O
GSK3β  	GSK3β  	 NNP	B-NP
could  	could  	 MD	O
regulate  	regulate  	 VB	O
p53  	p53  	 NN	B-NP
transcriptional  	transcriptional  	 NN	I-NP
activity  	activity  	 NN	I-NP
in  	in  	 IN	O
vivo 	vivo 	 NN	B-NP
.  	.  	 .	O
GSK3β  	GSK3β  	 NNP	B-NP
is  	is  	 VBZ	O
constitutively  	constitutively  	 JJ	O
active  	active  	 JJ	O
in  	in  	 IN	O
resting  	resting  	 JJ	O
cells 	cells 	 NNS	O
,  	,  	 ,	O
but  	but  	 CC	O
exhibits  	exhibits  	 VBZ	O
lower  	lower  	 JJR	O
activity  	activity  	 NN	O
in  	in  	 IN	O
asynchronously  	asynchronously  	 NNS	O
growing  	growing  	 VBG	O
cells  	cells  	 NNS	O
[  	[  	 -LRB-	O
24 	24 	 CD	O
] 	] 	 -RRB-	O
.  	.  	 .	O
To  	To  	 TO	O
increase  	increase  	 VB	O
the  	the  	 DT	O
activity  	activity  	 NN	O
of  	of  	 IN	O
GSK3β 	GSK3β 	 NNP	B-NP
,  	,  	 ,	O
we  	we  	 PRP	O
co-transfected  	co-transfected  	 JJ	B-NP
GSK3β  	GSK3β  	 NN	I-NP
with  	with  	 IN	O
either  	either  	 DT	O
wtp53  	wtp53  	 NNP	B-NP
or  	or  	 CC	O
p53  	p53  	 NN	B-NP
bearing  	bearing  	 NN	I-NP
serine  	serine  	 NN	I-NP
to  	to  	 TO	O
alanine  	alanine  	 VB	O
mutations  	mutations  	 VBN	O
at  	at  	 IN	O
positions  	positions  	 NNS	O
33  	33  	 CD	O
or  	or  	 CC	O
37 	37 	 CD	O
.  	.  	 .	O
GSK3β  	GSK3β  	 NNP	B-NP
increased  	increased  	 VBD	O
the  	the  	 DT	O
transcriptional  	transcriptional  	 JJ	B-NP
activity  	activity  	 NN	I-NP
of  	of  	 IN	I-NP
wtp53 	wtp53 	 NNP	I-NP
,  	,  	 ,	O
but  	but  	 CC	O
not  	not  	 RB	O
of  	of  	 IN	O
p53  	p53  	 NN	B-NP
with  	with  	 IN	O
mutations  	mutations  	 NNS	O
in  	in  	 IN	O
either  	either  	 DT	O
serine  	serine  	 JJ	O
33  	33  	 CD	O
or  	or  	 CC	O
37 	37 	 CD	O
.  	.  	 .	O
Therefore  	Therefore  	 RB	O
both  	both  	 DT	O
serine  	serine  	 JJ	O
33  	33  	 CD	O
and  	and  	 CC	O
serine  	serine  	 CD	B-NP
37  	37  	 CD	O
are  	are  	 VBP	O
required  	required  	 VBN	O
for  	for  	 IN	O
GSK3β  	GSK3β  	 CD	B-NP
to  	to  	 TO	O
activate  	activate  	 VB	O
p53  	p53  	 NN	B-NP
transcriptional  	transcriptional  	 NN	I-NP
activity  	activity  	 NN	I-NP
in  	in  	 IN	O
vivo 	vivo 	 NN	B-NP
.  	.  	 .	O
GSK3β  	GSK3β  	 NNP	B-NP
regulates  	regulates  	 VBZ	O
many  	many  	 JJ	O
stress  	stress  	 NN	O
activated  	activated  	 VBN	B-NP
transcription  	transcription  	 JJ	I-NP
factors 	factors 	 NNS	I-NP
.  	.  	 .	O
For  	For  	 IN	O
example 	example 	 NN	O
,  	,  	 ,	O
GSK3β  	GSK3β  	 NNP	B-NP
is  	is  	 VBZ	O
required  	required  	 VBN	O
for  	for  	 IN	O
activation  	activation  	 NN	B-NP
of  	of  	 IN	I-NP
NFκ  	NFκ  	 NNP	I-NP
B  	B  	 NNP	I-NP
[  	[  	 -LRB-	O
37 	37 	 CD	O
] 	] 	 -RRB-	O
,  	,  	 ,	O
but  	but  	 CC	O
inhibits  	inhibits  	 JJ	O
activation  	activation  	 NN	B-NP
of  	of  	 IN	I-NP
Heat  	Heat  	 NNP	I-NP
Shock  	Shock  	 NNP	I-NP
Factor-1  	Factor-1  	 NNP	I-NP
[  	[  	 -LRB-	O
27 	27 	 CD	O
] 	] 	 -RRB-	O
.  	.  	 .	O
Our  	Our  	 PRP$	O
results  	results  	 NNS	O
indicate  	indicate  	 VBP	O
that  	that  	 IN	O
GSK3β  	GSK3β  	 NNP	B-NP
may  	may  	 MD	O
also  	also  	 RB	O
be  	be  	 VB	O
involved  	involved  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
activation  	activation  	 NN	B-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
p53  	p53  	 NN	I-NP
protein  	protein  	 NN	I-NP
as  	as  	 IN	O
well 	well 	 RB	O
.  	.  	 .	O
A  	A  	 DT	O
key  	key  	 JJ	B-NP
question  	question  	 NN	I-NP
is  	is  	 VBZ	O
whether  	whether  	 IN	O
DNA-PK  	DNA-PK  	 JJ	B-NP
or  	or  	 CC	O
some  	some  	 DT	O
other  	other  	 JJ	O
kinase  	kinase  	 NN	B-NP
phosphorylates  	phosphorylates  	 VBD	O
serine  	serine  	 CD	B-NP
37  	37  	 CD	O
of  	of  	 IN	O
p53  	p53  	 NN	B-NP
in  	in  	 IN	O
vivo 	vivo 	 NN	B-NP
.  	.  	 .	O
DNA-PK  	DNA-PK  	 NNP	B-NP
is  	is  	 VBZ	O
460  	460  	 CD	O
kd  	kd  	 CD	B-NP
DNA-activated  	DNA-activated  	 JJ	I-NP
protein  	protein  	 NN	I-NP
kinase  	kinase  	 NNS	I-NP
which  	which  	 WDT	O
participates  	participates  	 VBZ	O
in  	in  	 IN	O
the  	the  	 DT	O
cellular  	cellular  	 JJ	B-NP
response  	response  	 NN	I-NP
to  	to  	 TO	O
DNA  	DNA  	 NNP	B-NP
damage  	damage  	 NN	I-NP
[  	[  	 -LRB-	O
41 	41 	 CD	O
] 	] 	 -RRB-	O
.  	.  	 .	O
DNA-PK  	DNA-PK  	 NNP	B-NP
is  	is  	 VBZ	O
involved  	involved  	 VBN	O
in  	in  	 IN	O
DNA  	DNA  	 NNP	B-NP
strand-break  	strand-break  	 JJ	I-NP
repair 	repair 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
can  	can  	 MD	O
phosphorylate  	phosphorylate  	 VB	O
serines  	serines  	 CD	B-NP
15  	15  	 CD	O
and  	and  	 CC	O
serine  	serine  	 CD	B-NP
37  	37  	 CD	O
of  	of  	 IN	O
p53  	p53  	 NN	B-NP
in  	in  	 IN	O
vitro  	vitro  	 NNS	B-NP
[  	[  	 -LRB-	O
32 	32 	 CD	O
] 	] 	 -RRB-	O
.  	.  	 .	O
Some  	Some  	 DT	O
reports  	reports  	 NNS	O
indicate  	indicate  	 VBP	O
that  	that  	 IN	O
DNA-PK  	DNA-PK  	 NNP	B-NP
is  	is  	 VBZ	O
required  	required  	 VBN	O
for  	for  	 IN	O
the  	the  	 DT	O
activation  	activation  	 NN	B-NP
of  	of  	 IN	I-NP
p53  	p53  	 NN	I-NP
[  	[  	 -LRB-	O
42 	42 	 CD	O
] 	] 	 -RRB-	O
,  	,  	 ,	O
but  	but  	 CC	O
recent  	recent  	 JJ	O
genetic  	genetic  	 JJ	B-NP
studies  	studies  	 NNS	I-NP
have  	have  	 VBP	O
shown  	shown  	 VBN	O
clearly  	clearly  	 RB	O
that  	that  	 IN	O
DNA-PK  	DNA-PK  	 NNP	B-NP
is  	is  	 VBZ	O
not  	not  	 RB	O
required  	required  	 VBN	O
for  	for  	 IN	O
p53  	p53  	 NN	B-NP
activation  	activation  	 NN	I-NP
by  	by  	 IN	O
Ionizing  	Ionizing  	 NNP	B-NP
Radiation  	Radiation  	 NNP	I-NP
[  	[  	 -LRB-	O
43 	43 	 CD	O
] 	] 	 -RRB-	O
.  	.  	 .	O
Whether  	Whether  	 IN	O
DNA-PK  	DNA-PK  	 NNP	B-NP
is  	is  	 VBZ	O
required  	required  	 VBN	O
for  	for  	 IN	O
p53  	p53  	 NN	B-NP
activation  	activation  	 NN	I-NP
in  	in  	 IN	O
response  	response  	 NN	O
to  	to  	 TO	O
other  	other  	 JJ	O
stimuli  	stimuli  	 NN	O
is  	is  	 VBZ	O
not  	not  	 RB	O
known 	known 	 VBN	O
.  	.  	 .	O
A  	A  	 DT	O
more  	more  	 RBR	O
likely  	likely  	 JJ	O
candidate  	candidate  	 NN	O
is  	is  	 VBZ	O
the  	the  	 DT	O
Atr  	Atr  	 JJ	B-NP
protein  	protein  	 NN	I-NP
kinase 	kinase 	 NN	I-NP
,  	,  	 ,	O
a  	a  	 DT	O
kinase  	kinase  	 NN	B-NP
related  	related  	 VBN	O
to  	to  	 TO	O
DNA-PK  	DNA-PK  	 NNP	B-NP
[  	[  	 -LRB-	O
44 	44 	 CD	O
] 	] 	 -RRB-	O
,  	,  	 ,	O
which  	which  	 WDT	O
can  	can  	 MD	O
regulate  	regulate  	 VB	O
the  	the  	 DT	O
phosphorylation  	phosphorylation  	 NN	B-NP
of  	of  	 IN	I-NP
serine  	serine  	 CD	I-NP
37  	37  	 CD	O
of  	of  	 IN	O
p53  	p53  	 NN	B-NP
in  	in  	 IN	O
response  	response  	 NN	O
to  	to  	 TO	O
DNA  	DNA  	 NNP	B-NP
damage 	damage 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
present  	present  	 JJ	O
data  	data  	 NN	O
indicates  	indicates  	 VBZ	O
that  	that  	 DT	O
transcriptional  	transcriptional  	 JJ	B-NP
activation  	activation  	 NN	I-NP
of  	of  	 IN	I-NP
p53  	p53  	 NN	I-NP
by  	by  	 IN	O
GSK3β  	GSK3β  	 NNP	B-NP
requires  	requires  	 VBZ	O
both  	both  	 DT	O
serines  	serines  	 JJ	O
33  	33  	 CD	O
and  	and  	 CC	O
37 	37 	 CD	O
,  	,  	 ,	O
but  	but  	 CC	O
it  	it  	 PRP	O
does  	does  	 VBZ	O
not  	not  	 RB	O
allow  	allow  	 VB	O
us  	us  	 PRP	O
to  	to  	 TO	O
determine  	determine  	 VB	O
if  	if  	 IN	O
phosphorylation  	phosphorylation  	 NN	B-NP
of  	of  	 IN	I-NP
serine  	serine  	 CD	I-NP
33  	33  	 CD	O
is  	is  	 VBZ	O
dependent  	dependent  	 JJ	O
on  	on  	 IN	O
phosphorylation  	phosphorylation  	 NN	B-NP
of  	of  	 IN	I-NP
serine  	serine  	 CD	I-NP
37  	37  	 CD	O
in  	in  	 IN	O
vivo 	vivo 	 NN	B-NP
.  	.  	 .	O
It  	It  	 PRP	O
is  	is  	 VBZ	O
possible  	possible  	 JJ	O
that 	that 	 IN	O
,  	,  	 ,	O
in  	in  	 IN	O
vivo 	vivo 	 NN	B-NP
,  	,  	 ,	O
GSK3β  	GSK3β  	 NNP	B-NP
directly  	directly  	 RB	O
phosphorylates  	phosphorylates  	 CD	B-NP
serine  	serine  	 CD	I-NP
33  	33  	 CD	O
independently  	independently  	 NN	O
of  	of  	 IN	O
serine  	serine  	 CD	B-NP
37 	37 	 CD	O
,  	,  	 ,	O
but  	but  	 CC	O
that  	that  	 IN	O
both  	both  	 DT	O
residues  	residues  	 NN	O
must  	must  	 MD	O
be  	be  	 VB	O
phosphorylated  	phosphorylated  	 VBN	O
for  	for  	 IN	O
transcriptional  	transcriptional  	 JJ	B-NP
activation  	activation  	 NN	I-NP
to  	to  	 TO	O
occur  	occur  	 VB	O
in  	in  	 IN	O
vivo 	vivo 	 NN	B-NP
.  	.  	 .	O
Future  	Future  	 JJ	O
studies  	studies  	 NNS	O
will  	will  	 MD	O
address  	address  	 VB	O
this  	this  	 DT	O
issue.  	issue.  	 JJ	O
p53  	p53  	 NN	B-NP
is  	is  	 VBZ	O
activated  	activated  	 VBN	O
by  	by  	 IN	O
multiple  	multiple  	 JJ	O
pathways 	pathways 	 NN	O
,  	,  	 ,	O
including  	including  	 VBG	B-NP
DNA  	DNA  	 NN	I-NP
damage  	damage  	 NN	I-NP
and  	and  	 CC	O
oncogene  	oncogene  	 JJ	B-NP
activation  	activation  	 NNS	I-NP
[  	[  	 -LRB-	O
1 	1 	 CD	O
,  	,  	 ,	O
2 	2 	 CD	O
,  	,  	 ,	O
3 	3 	 LS	O
] 	] 	 -RRB-	O
.  	.  	 .	O
If  	If  	 IN	O
GSK3β  	GSK3β  	 NNP	B-NP
is  	is  	 VBZ	O
required  	required  	 VBN	O
for  	for  	 IN	O
the  	the  	 DT	O
activation  	activation  	 NN	B-NP
of  	of  	 IN	I-NP
p53  	p53  	 NN	I-NP
by  	by  	 IN	O
DNA  	DNA  	 NNP	B-NP
damage 	damage 	 NN	I-NP
,  	,  	 ,	O
GSK3β  	GSK3β  	 CD	B-NP
activity  	activity  	 NN	I-NP
should  	should  	 MD	O
be  	be  	 VB	O
regulated  	regulated  	 VBN	O
by  	by  	 IN	O
DNA  	DNA  	 NNP	B-NP
damage 	damage 	 NN	I-NP
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
when  	when  	 WRB	O
cells  	cells  	 NNS	O
were  	were  	 VBD	O
exposed  	exposed  	 VBN	O
to  	to  	 TO	O
Ionizing  	Ionizing  	 NNP	B-NP
Radiation 	Radiation 	 NNP	I-NP
,  	,  	 ,	O
GSK3β  	GSK3β  	 CD	B-NP
kinase  	kinase  	 JJ	I-NP
activity  	activity  	 NN	I-NP
was  	was  	 VBD	O
inhibited  	inhibited  	 VBN	O
rather  	rather  	 RB	O
than  	than  	 IN	O
enhanced 	enhanced 	 JJ	O
,  	,  	 ,	O
implying  	implying  	 VBG	O
decreased  	decreased  	 VBN	B-NP
GSK3β-dependent  	GSK3β-dependent  	 CD	I-NP
phosphorylation  	phosphorylation  	 NN	I-NP
of  	of  	 IN	I-NP
p53  	p53  	 NN	I-NP
after  	after  	 IN	O
DNA  	DNA  	 NNP	B-NP
damage 	damage 	 NN	I-NP
.  	.  	 .	O
Serine  	Serine  	 NNP	B-NP
33  	33  	 CD	O
of  	of  	 IN	O
p53  	p53  	 NN	B-NP
is  	is  	 VBZ	O
also  	also  	 RB	O
phosphorylated  	phosphorylated  	 VBN	O
by  	by  	 IN	O
other  	other  	 JJ	O
kinases 	kinases 	 NN	B-NP
,  	,  	 ,	O
including  	including  	 VBG	O
the  	the  	 DT	O
CDK7-cyclin  	CDK7-cyclin  	 NNP	B-NP
H  	H  	 NNP	I-NP
complex  	complex  	 NN	I-NP
[  	[  	 -LRB-	O
45 	45 	 CD	O
]  	]  	 -RRB-	O
and  	and  	 CC	O
p38  	p38  	 NNP	B-NP
MAPK  	MAPK  	 NNP	I-NP
[  	[  	 -LRB-	O
46 	46 	 CD	O
] 	] 	 -RRB-	O
.  	.  	 .	O
p38  	p38  	 FW	B-NP
MAPK  	MAPK  	 FW	I-NP
is  	is  	 VBZ	O
involved  	involved  	 VBN	O
in  	in  	 IN	O
p53  	p53  	 NN	B-NP
activation  	activation  	 NN	I-NP
by  	by  	 IN	O
genotoxic  	genotoxic  	 JJ	B-NP
stress  	stress  	 NN	I-NP
[  	[  	 -LRB-	O
46 	46 	 CD	O
] 	] 	 -RRB-	O
,  	,  	 ,	O
and  	and  	 CC	O
may  	may  	 MD	O
be  	be  	 VB	O
responsible  	responsible  	 JJ	O
for  	for  	 IN	O
p53  	p53  	 NN	B-NP
phosphorylation  	phosphorylation  	 NN	I-NP
at  	at  	 IN	O
serine  	serine  	 CD	B-NP
33  	33  	 CD	O
in  	in  	 IN	O
response  	response  	 NN	O
to  	to  	 TO	O
DNA  	DNA  	 NNP	B-NP
damage 	damage 	 NN	I-NP
.  	.  	 .	O
GSK3β-dependent  	GSK3β-dependent  	 NNP	B-NP
phosphorylation  	phosphorylation  	 NN	I-NP
of  	of  	 IN	I-NP
p53  	p53  	 NN	I-NP
at  	at  	 IN	O
serine  	serine  	 CD	B-NP
33  	33  	 CD	O
may  	may  	 MD	O
be  	be  	 VB	O
part  	part  	 NN	O
of  	of  	 IN	O
other  	other  	 JJ	O
p53-regulatory  	p53-regulatory  	 CD	B-NP
pathways 	pathways 	 NN	I-NP
,  	,  	 ,	O
such  	such  	 JJ	O
as  	as  	 IN	O
oncogene  	oncogene  	 JJ	B-NP
activation  	activation  	 NN	I-NP
or  	or  	 CC	O
apoptosis 	apoptosis 	 NN	B-NP
,  	,  	 ,	O
which  	which  	 WDT	O
are  	are  	 VBP	O
not  	not  	 RB	O
directly  	directly  	 RB	O
activated  	activated  	 VBN	O
by  	by  	 IN	O
DNA-damage 	DNA-damage 	 JJ	B-NP
.  	.  	 .	O
For  	For  	 IN	O
example 	example 	 NN	O
,  	,  	 ,	O
activation  	activation  	 VBG	O
of  	of  	 IN	O
the  	the  	 DT	O
p110-PI  	p110-PI  	 NNP	O
3-kinase 	3-kinase 	 NNP	O
/ 	/ 	 NNP	O
PKB  	PKB  	 NNP	O
pathway  	pathway  	 NN	O
delivers  	delivers  	 VBZ	O
an  	an  	 DT	O
anti-apoptotic  	anti-apoptotic  	 JJ	B-NP
signal  	signal  	 NN	I-NP
to  	to  	 TO	O
the  	the  	 DT	O
cell  	cell  	 NN	O
[  	[  	 -LRB-	O
23 	23 	 CD	O
,  	,  	 ,	O
25 	25 	 CD	O
,  	,  	 ,	O
47 	47 	 CD	O
] 	] 	 -RRB-	O
.  	.  	 .	O
Further 	Further 	 RB	O
,  	,  	 ,	O
activation  	activation  	 VBG	O
of  	of  	 IN	O
the  	the  	 DT	O
p110-PI  	p110-PI  	 NNP	O
3-kinase 	3-kinase 	 NNP	O
/ 	/ 	 NNP	O
PKB  	PKB  	 NNP	O
is  	is  	 VBZ	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
inhibition  	inhibition  	 NN	O
of  	of  	 IN	O
both  	both  	 DT	O
p53  	p53  	 NN	B-NP
dependent  	dependent  	 JJ	O
apoptosis  	apoptosis  	 NNS	B-NP
[  	[  	 -LRB-	O
48 	48 	 CD	O
]  	]  	 -RRB-	O
and  	and  	 CC	O
p53  	p53  	 NN	B-NP
transcriptional  	transcriptional  	 NN	I-NP
activity  	activity  	 NN	I-NP
[  	[  	 -LRB-	O
49 	49 	 CD	O
,  	,  	 ,	O
50 	50 	 CD	O
] 	] 	 -RRB-	O
.  	.  	 .	O
Although  	Although  	 IN	O
PKB  	PKB  	 NNP	B-NP
has  	has  	 VBZ	O
many  	many  	 JJ	O
down  	down  	 IN	O
stream  	stream  	 NN	B-NP
targets  	targets  	 NNS	I-NP
which  	which  	 WDT	O
may  	may  	 MD	O
regulate  	regulate  	 VB	O
these  	these  	 DT	O
effects  	effects  	 NNS	O
[  	[  	 -LRB-	O
47 	47 	 CD	O
]  	]  	 -RRB-	O
a  	a  	 DT	O
key  	key  	 JJ	B-NP
target  	target  	 NN	I-NP
of  	of  	 IN	I-NP
PKB  	PKB  	 NNP	I-NP
is  	is  	 VBZ	O
GSK3β  	GSK3β  	 NNP	B-NP
[  	[  	 -LRB-	O
29 	29 	 CD	O
] 	] 	 -RRB-	O
.  	.  	 .	O
Phosphorylation  	Phosphorylation  	 NNP	B-NP
of  	of  	 IN	I-NP
GSK3β  	GSK3β  	 CD	I-NP
by  	by  	 IN	O
PKB  	PKB  	 NNP	B-NP
inhibits  	inhibits  	 FW	O
GSK3β  	GSK3β  	 FW	B-NP
kinase  	kinase  	 FW	I-NP
activity  	activity  	 FW	I-NP
[  	[  	 -LRB-	O
29 	29 	 CD	O
] 	] 	 -RRB-	O
.  	.  	 .	O
This  	This  	 DT	O
would  	would  	 MD	O
be  	be  	 VB	O
predicted  	predicted  	 VBN	O
to  	to  	 TO	O
block  	block  	 VB	O
phosphorylation  	phosphorylation  	 VBN	O
of  	of  	 IN	O
serine  	serine  	 CD	B-NP
33  	33  	 CD	O
of  	of  	 IN	O
p53  	p53  	 NN	B-NP
by  	by  	 IN	O
GSK3β 	GSK3β 	 NNP	B-NP
,  	,  	 ,	O
decreasing  	decreasing  	 VBG	B-NP
p53  	p53  	 NN	I-NP
transcriptional  	transcriptional  	 NN	I-NP
activity  	activity  	 NN	I-NP
and  	and  	 CC	O
therefore  	therefore  	 RB	O
reducing  	reducing  	 VBG	O
the  	the  	 DT	O
transcription  	transcription  	 NN	B-NP
of  	of  	 IN	I-NP
p53-regulated  	p53-regulated  	 CD	I-NP
growth  	growth  	 NN	I-NP
and  	and  	 CC	O
pro-apoptotic  	pro-apoptotic  	 JJ	B-NP
proteins 	proteins 	 NNS	I-NP
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
clarification  	clarification  	 NN	B-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
potential  	potential  	 JJ	I-NP
role  	role  	 NN	I-NP
of  	of  	 IN	I-NP
GSK3β  	GSK3β  	 CD	I-NP
in  	in  	 IN	O
regulating  	regulating  	 VBG	B-NP
p53  	p53  	 NN	I-NP
activation  	activation  	 NN	I-NP
by  	by  	 IN	O
non-DNA  	non-DNA  	 JJ	B-NP
damage  	damage  	 NN	I-NP
pathways  	pathways  	 NNS	I-NP
will  	will  	 MD	O
require  	require  	 VB	O
additional  	additional  	 JJ	O
study 	study 	 NN	O
.  	.  	 .	O
Conclusions  	Conclusions  	 NNS	O
This  	This  	 DT	O
study  	study  	 NN	O
demonstrates  	demonstrates  	 VBZ	O
that  	that  	 IN	O
GSK3β 	GSK3β 	 NNP	B-NP
,  	,  	 ,	O
but  	but  	 CC	O
not  	not  	 RB	O
GSK3α 	GSK3α 	 CD	B-NP
,  	,  	 ,	O
can  	can  	 MD	O
directly  	directly  	 RB	O
phosphorylate  	phosphorylate  	 CD	B-NP
serine  	serine  	 CD	I-NP
33  	33  	 CD	O
of  	of  	 IN	O
p53  	p53  	 NN	B-NP
when  	when  	 WRB	O
serine  	serine  	 JJ	O
37  	37  	 CD	O
of  	of  	 IN	O
p53  	p53  	 NN	B-NP
is  	is  	 VBZ	O
already  	already  	 RB	O
phosphorylated 	phosphorylated 	 VBN	O
.  	.  	 .	O
GSK3β  	GSK3β  	 NNP	B-NP
can  	can  	 MD	O
increase  	increase  	 VB	O
p53 	p53 	 NN	O
's  	's  	 POS	O
transcriptional  	transcriptional  	 JJ	B-NP
activity  	activity  	 NN	I-NP
in  	in  	 IN	O
vivo 	vivo 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
this  	this  	 DT	O
activation  	activation  	 NN	B-NP
requires  	requires  	 VBZ	O
serines  	serines  	 CD	B-NP
33  	33  	 CD	O
and  	and  	 CC	O
37  	37  	 CD	O
of  	of  	 IN	O
the  	the  	 DT	O
p53  	p53  	 NN	B-NP
protein 	protein 	 NN	I-NP
.  	.  	 .	O
Thus  	Thus  	 RB	O
GSK3β  	GSK3β  	 CD	B-NP
may  	may  	 MD	O
phosphorylate  	phosphorylate  	 VB	O
and  	and  	 CC	O
activate  	activate  	 JJ	B-NP
p53  	p53  	 NN	I-NP
in  	in  	 IN	O
vivo 	vivo 	 NN	B-NP
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
GSK3β  	GSK3β  	 NNP	B-NP
is  	is  	 VBZ	O
not  	not  	 RB	O
part  	part  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
p53-DNA  	p53-DNA  	 JJ	B-NP
damage  	damage  	 NN	I-NP
response  	response  	 NN	I-NP
pathway 	pathway 	 NN	I-NP
.  	.  	 .	O
Instead 	Instead 	 RB	O
,  	,  	 ,	O
GSK3β  	GSK3β  	 NNP	B-NP
may  	may  	 MD	O
provide  	provide  	 VB	O
the  	the  	 DT	O
link  	link  	 NN	O
between  	between  	 IN	O
p53  	p53  	 NN	B-NP
and  	and  	 CC	O
non-DNA  	non-DNA  	 JJ	B-NP
damage  	damage  	 NN	I-NP
mechanisms  	mechanisms  	 NNS	I-NP
for  	for  	 IN	I-NP
p53  	p53  	 NN	I-NP
activation 	activation 	 NN	I-NP
,  	,  	 ,	O
such  	such  	 JJ	O
as  	as  	 IN	O
oncogene  	oncogene  	 JJ	B-NP
activation 	activation 	 NN	I-NP
.  	.  	 .	O
Materials  	Materials  	 NNS	O
and  	and  	 CC	O
methods  	methods  	 NNS	O
Phosphorylation  	Phosphorylation  	 NNP	B-NP
Reactions  	Reactions  	 NNP	I-NP
Wild  	Wild  	 NNP	O
type  	type  	 NN	B-NP
p53  	p53  	 NN	I-NP
or  	or  	 CC	O
p53  	p53  	 NN	B-NP
bearing  	bearing  	 NN	I-NP
mutations  	mutations  	 NNS	I-NP
in  	in  	 IN	O
serines  	serines  	 CD	B-NP
33  	33  	 CD	O
or  	or  	 CC	O
37  	37  	 CD	O
were  	were  	 VBD	O
subcloned  	subcloned  	 VBN	O
into  	into  	 IN	O
pGEX-2T  	pGEX-2T  	 NNP	B-NP
GST  	GST  	 NNP	I-NP
fusion  	fusion  	 NN	I-NP
vector  	vector  	 NN	I-NP
( 	( 	 -LRB-	O
Pharmacia 	Pharmacia 	 NNP	B-NP
,  	,  	 ,	O
NJ 	NJ 	 NNP	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
p53-GST  	p53-GST  	 CD	B-NP
purified  	purified  	 NN	I-NP
as  	as  	 IN	O
previously  	previously  	 RB	O
described  	described  	 VBN	O
[  	[  	 -LRB-	O
33 	33 	 CD	O
] 	] 	 -RRB-	O
.  	.  	 .	O
p53-GST  	p53-GST  	 FW	B-NP
protein  	protein  	 FW	I-NP
( 	( 	 -LRB-	O
2  	2  	 CD	O
μg 	μg 	 NNS	B-NP
;  	;  	 :	O
measured  	measured  	 VBN	O
using  	using  	 VBG	O
Bio-Rad  	Bio-Rad  	 JJ	B-NP
Protein  	Protein  	 NNP	I-NP
assay  	assay  	 VBD	O
Kit 	Kit 	 NNP	O
,  	,  	 ,	O
Biorad 	Biorad 	 NNP	B-NP
,  	,  	 ,	O
CA 	CA 	 NNP	B-NP
)  	)  	 -RRB-	O
was  	was  	 VBD	O
incubated  	incubated  	 VBN	O
with  	with  	 IN	O
MAP  	MAP  	 NNP	B-NP
kinase  	kinase  	 NNS	I-NP
( 	( 	 -LRB-	O
Erk2 	Erk2 	 NNP	B-NP
,  	,  	 ,	O
10  	10  	 CD	O
Units 	Units 	 NNS	O
,  	,  	 ,	O
New  	New  	 NNP	B-NP
England  	England  	 NNP	I-NP
Biolabs 	Biolabs 	 NNP	I-NP
,  	,  	 ,	O
MA 	MA 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
Protein  	Protein  	 NNP	B-NP
Kinase  	Kinase  	 NNP	I-NP
A  	A  	 NNP	O
( 	( 	 -LRB-	O
Catalytic  	Catalytic  	 NNP	B-NP
sub-unit 	sub-unit 	 NNP	I-NP
,  	,  	 ,	O
5  	5  	 CD	O
Units 	Units 	 NNS	O
,  	,  	 ,	O
Calbiochem 	Calbiochem 	 NNP	B-NP
,  	,  	 ,	O
CA 	CA 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
S6  	S6  	 CD	B-NP
kinase  	kinase  	 NNS	I-NP
( 	( 	 -LRB-	O
0.2  	0.2  	 CD	O
Units 	Units 	 NNS	O
,  	,  	 ,	O
Upstate  	Upstate  	 NNP	O
Biotechnology 	Biotechnology 	 NNP	O
,  	,  	 ,	O
NY 	NY 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
Protein  	Protein  	 NNP	B-NP
Kinase  	Kinase  	 NNP	I-NP
C  	C  	 NNP	I-NP
( 	( 	 -LRB-	O
O.1  	O.1  	 NNP	O
mUnits 	mUnits 	 NNP	B-NP
,  	,  	 ,	O
Roche  	Roche  	 NNP	O
Molecular  	Molecular  	 NNP	B-NP
Biochemicals 	Biochemicals 	 NNP	I-NP
,  	,  	 ,	O
IN 	IN 	 IN	O
)  	)  	 -RRB-	O
or  	or  	 CC	O
DNA-PK  	DNA-PK  	 NNP	B-NP
( 	( 	 -LRB-	O
20  	20  	 CD	O
Units 	Units 	 NNS	O
,  	,  	 ,	O
Promega  	Promega  	 NNP	B-NP
Corp 	Corp 	 NNP	O
,  	,  	 ,	O
Wl 	Wl 	 NNP	B-NP
)  	)  	 -RRB-	O
for  	for  	 IN	O
5  	5  	 CD	O
h  	h  	 NN	O
at  	at  	 IN	O
30°C  	30°C  	 CD	O
in  	in  	 IN	O
the  	the  	 DT	O
following  	following  	 JJ	O
buffers  	buffers  	 NNS	O
( 	( 	 -LRB-	O
40  	40  	 CD	O
μl  	μl  	 CD	B-NP
final  	final  	 JJ	I-NP
volume 	volume 	 NN	I-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
MAP  	MAP  	 NN	B-NP
kinase  	kinase  	 NNS	I-NP
and  	and  	 CC	O
Protein  	Protein  	 NNP	B-NP
Kinase  	Kinase  	 NNP	I-NP
A 	A 	 NNP	O
:  	:  	 :	O
20  	20  	 CD	O
mM  	mM  	 JJ	B-NP
Hepes  	Hepes  	 NNP	I-NP
pH  	pH  	 NNP	I-NP
7.2 	7.2 	 CD	O
/ 	/ 	 CD	O
10  	10  	 CD	O
mM  	mM  	 JJ	B-NP
Na-Acetate 	Na-Acetate 	 JJ	I-NP
/ 	/ 	 CD	O
30  	30  	 CD	O
mM  	mM  	 JJ	O
MgCl  	MgCl  	 JJ	B-NP
2  	2  	 CD	O
/ 	/ 	 CD	O
0.2  	0.2  	 CD	O
mM  	mM  	 JJ	B-NP
EDTA 	EDTA 	 NNP	I-NP
/ 	/ 	 CD	O
1  	1  	 CD	O
mM  	mM  	 JJ	B-NP
EDTA 	EDTA 	 NNP	I-NP
/ 	/ 	 NNP	O
I0  	I0  	 NNP	B-NP
μM  	μM  	 NNP	I-NP
ATP 	ATP 	 NNP	I-NP
.  	.  	 .	O
S6  	S6  	 NNP	B-NP
Kinase 	Kinase 	 NNP	I-NP
:  	:  	 :	O
20  	20  	 CD	O
mM  	mM  	 JJ	O
MOPS  	MOPS  	 NNP	O
pH  	pH  	 NNP	B-NP
7.2 	7.2 	 CD	O
/ 	/ 	 CD	O
30  	30  	 CD	O
mM  	mM  	 JJ	O
MgCl  	MgCl  	 JJ	B-NP
2  	2  	 CD	O
/ 	/ 	 CD	O
5  	5  	 CD	O
mM  	mM  	 JJ	B-NP
EGTA 	EGTA 	 NNP	I-NP
/ 	/ 	 CD	O
1  	1  	 CD	O
mM  	mM  	 JJ	B-NP
DTT 	DTT 	 NNP	I-NP
/ 	/ 	 NNP	O
I0  	I0  	 NNP	B-NP
μM  	μM  	 NNP	I-NP
ATP 	ATP 	 NNP	I-NP
.  	.  	 .	O
DNA-PK 	DNA-PK 	 NNP	O
: 	: 	 :	O
25  	25  	 CD	O
mM  	mM  	 JJ	O
Hepes  	Hepes  	 NNP	O
pH7.5 	pH7.5 	 CD	O
/ 	/ 	 CD	O
150  	150  	 CD	O
mM  	mM  	 JJ	O
KCI 	KCI 	 NNP	O
/ 	/ 	 CD	O
10  	10  	 CD	O
mM  	mM  	 JJ	O
MgCl  	MgCl  	 JJ	O
2  	2  	 CD	O
/ 	/ 	 CD	O
20 	20 	 CD	O
%  	%  	 NN	O
Glycerol 	Glycerol 	 NNP	O
/ 	/ 	 CD	O
0.1 	0.1 	 CD	O
%  	%  	 NN	O
NP40 	NP40 	 CD	O
/ 	/ 	 CD	O
20  	20  	 CD	O
μM  	μM  	 JJ	O
ZnCl  	ZnCl  	 JJ	O
2  	2  	 CD	O
/ 	/ 	 CD	O
1  	1  	 CD	O
mM  	mM  	 JJ	O
DTT 	DTT 	 NNP	O
/ 	/ 	 CD	O
250  	250  	 CD	O
ng  	ng  	 JJ	O
DNA 	DNA 	 NN	O
/ 	/ 	 CD	O
4.2  	4.2  	 CD	O
mM  	mM  	 JJ	O
spermidine 	spermidine 	 NN	O
/  	/  	 CD	O
10  	10  	 CD	O
μM  	μM  	 JJ	O
ATP 	ATP 	 NNP	O
.  	.  	 .	O
PKC 	PKC 	 NNP	O
:  	:  	 :	O
20  	20  	 CD	O
mM  	mM  	 JJ	O
Hepes  	Hepes  	 NNP	O
pH  	pH  	 NNP	O
7.4 	7.4 	 CD	O
/  	/  	 CD	O
20  	20  	 CD	O
mM  	mM  	 JJ	O
MgCl  	MgCl  	 JJ	O
2  	2  	 CD	O
/  	/  	 CD	O
0.2  	0.2  	 CD	O
mM  	mM  	 JJ	O
EGTA 	EGTA 	 NNP	O
/  	/  	 CD	O
1  	1  	 CD	O
mM  	mM  	 JJ	O
CaCl  	CaCl  	 JJ	O
2  	2  	 CD	O
/ 	/ 	 CD	O
1.5  	1.5  	 CD	O
μg  	μg  	 CD	O
phosphatidylserine 	phosphatidylserine 	 NNS	O
.  	.  	 .	O
Samples  	Samples  	 NNS	O
were  	were  	 VBD	O
then  	then  	 RB	O
incubated  	incubated  	 VBN	O
at  	at  	 IN	O
65°C  	65°C  	 CD	O
for  	for  	 IN	O
20  	20  	 CD	O
min  	min  	 NN	O
to  	to  	 TO	O
inactivate  	inactivate  	 VB	O
kinases 	kinases 	 NNS	O
,  	,  	 ,	O
and  	and  	 CC	O
25 	25 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
reaction  	reaction  	 NN	O
incubated  	incubated  	 NN	O
for  	for  	 IN	O
30  	30  	 CD	O
min  	min  	 NN	O
with  	with  	 IN	O
GSK3α  	GSK3α  	 NNP	O
or  	or  	 CC	O
GSK3β  	GSK3β  	 CD	O
in  	in  	 IN	O
GSK3  	GSK3  	 FW	O
kinase  	kinase  	 FW	O
buffer  	buffer  	 FW	O
( 	( 	 -LRB-	O
KGB  	KGB  	 NNP	O
Buffer 	Buffer 	 NNP	O
:  	:  	 :	O
8  	8  	 CD	O
mM  	mM  	 JJ	O
MOPS 	MOPS 	 NNP	O
,  	,  	 ,	O
pH7.2 	pH7.2 	 CD	O
/  	/  	 CD	O
10  	10  	 CD	O
mM  	mM  	 JJ	O
MgCl  	MgCl  	 JJ	O
2  	2  	 CD	O
/  	/  	 CD	O
0.2  	0.2  	 CD	O
mM  	mM  	 JJ	O
EDTA 	EDTA 	 NNP	O
/  	/  	 CD	O
5  	5  	 CD	O
μM  	μM  	 JJ	O
ATP 	ATP 	 NNP	O
/ 	/ 	 CD	O
10  	10  	 CD	O
μCi  	μCi  	 JJ	O
32P-ATP 	32P-ATP 	 CD	O
)  	)  	 -RRB-	O
in  	in  	 IN	O
a  	a  	 DT	O
final  	final  	 JJ	O
volume  	volume  	 NN	O
of  	of  	 IN	O
40  	40  	 CD	O
μl 	μl 	 NNS	O
.  	.  	 .	O
Reactions  	Reactions  	 NNS	O
were  	were  	 VBD	O
terminated  	terminated  	 VBN	O
by  	by  	 IN	O
the  	the  	 DT	O
addition  	addition  	 NN	O
of  	of  	 IN	O
SDS  	SDS  	 NNP	O
sample  	sample  	 NN	O
buffer  	buffer  	 NN	O
and  	and  	 CC	O
p53-GST  	p53-GST  	 NNP	O
phosphorylation  	phosphorylation  	 VBD	O
detected  	detected  	 VBN	O
by  	by  	 IN	O
SDS-PAGE  	SDS-PAGE  	 JJ	O
and  	and  	 CC	O
auotradiography 	auotradiography 	 NN	O
.  	.  	 .	O
Equal  	Equal  	 JJ	O
amounts  	amounts  	 NNS	O
of  	of  	 IN	O
p53-GST  	p53-GST  	 NNP	O
( 	( 	 -LRB-	O
0.25  	0.25  	 CD	O
μg 	μg 	 CD	O
)  	)  	 -RRB-	O
were  	were  	 VBD	O
analyzed  	analyzed  	 VBN	O
by  	by  	 IN	O
SDS-PAGE  	SDS-PAGE  	 JJ	O
and  	and  	 CC	O
equal  	equal  	 JJ	O
loading  	loading  	 NN	O
confirmed  	confirmed  	 VBD	O
by  	by  	 IN	O
coomassie  	coomassie  	 JJ	O
blue  	blue  	 JJ	O
staining  	staining  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
SDS-PAG 	SDS-PAG 	 JJ	O
.  	.  	 .	O
GSK3  	GSK3  	 FW	B-NP
immunokinase  	immunokinase  	 FW	I-NP
assay  	assay  	 FW	I-NP
SAOS-2  	SAOS-2  	 FW	I-NP
cells  	cells  	 FW	I-NP
( 	( 	 -LRB-	O
5  	5  	 CD	O
×  	×  	 CD	O
10  	10  	 CD	O
6 	6 	 CD	O
)  	)  	 -RRB-	O
were  	were  	 VBD	O
lyzed  	lyzed  	 VBN	O
in  	in  	 IN	O
0.5  	0.5  	 CD	O
ml  	ml  	 NN	O
of  	of  	 IN	O
GLB  	GLB  	 NNP	B-NP
buffer  	buffer  	 NN	I-NP
( 	( 	 -LRB-	O
50  	50  	 CD	O
mM  	mM  	 JJ	B-NP
Tris  	Tris  	 NNP	I-NP
pH7.5 	pH7.5 	 CD	I-NP
/ 	/ 	 CD	O
1  	1  	 CD	O
mM  	mM  	 JJ	B-NP
EDTA 	EDTA 	 NNP	I-NP
/ 	/ 	 CD	O
1  	1  	 CD	O
mM  	mM  	 JJ	B-NP
EGTA 	EGTA 	 NNP	I-NP
/ 	/ 	 CD	O
0.5 	0.5 	 CD	O
%  	%  	 NN	O
NP40 	NP40 	 CD	B-NP
/ 	/ 	 CD	O
0.5  	0.5  	 CD	O
M  	M  	 NNP	O
NaCI 	NaCI 	 NNP	B-NP
/ 	/ 	 CD	O
1  	1  	 CD	O
mM  	mM  	 JJ	B-NP
DTT 	DTT 	 NNP	I-NP
/ 	/ 	 CD	O
1  	1  	 CD	O
mM  	mM  	 JJ	B-NP
PMSF 	PMSF 	 NNP	I-NP
/ 	/ 	 CD	I-NP
leupeptin 	leupeptin 	 CD	I-NP
/ 	/ 	 CD	I-NP
aprotinin 	aprotinin 	 CD	I-NP
/ 	/ 	 CD	O
600  	600  	 CD	O
μM  	μM  	 JJ	O
Na  	Na  	 NNP	O
3  	3  	 CD	O
VO  	VO  	 CD	B-NP
4  	4  	 CD	O
/ 	/ 	 CD	O
50  	50  	 CD	O
mM  	mM  	 JJ	B-NP
NaF 	NaF 	 NN	I-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
Extracts  	Extracts  	 NNP	O
were  	were  	 VBD	O
cleared  	cleared  	 VBN	O
by  	by  	 IN	O
centrifugation  	centrifugation  	 NN	B-NP
and  	and  	 CC	O
incubated  	incubated  	 NN	O
with  	with  	 IN	O
GSK3  	GSK3  	 CD	B-NP
antibody  	antibody  	 NN	I-NP
( 	( 	 -LRB-	O
1  	1  	 CD	O
μg 	μg 	 NNS	B-NP
;  	;  	 :	O
Upstate  	Upstate  	 NNP	B-NP
Biotech 	Biotech 	 NNP	I-NP
,  	,  	 ,	O
NY 	NY 	 NNP	B-NP
)  	)  	 -RRB-	O
prebound  	prebound  	 NN	B-NP
to  	to  	 TO	O
Sepharose  	Sepharose  	 NNP	B-NP
A 	A 	 NNP	I-NP
/ 	/ 	 NNP	I-NP
G  	G  	 NNP	I-NP
agarose  	agarose  	 VBD	O
beads  	beads  	 VBN	O
for  	for  	 IN	O
2  	2  	 CD	O
h 	h 	 NNS	O
.  	.  	 .	O
The  	The  	 DT	O
beads  	beads  	 NN	O
were  	were  	 VBD	O
washed  	washed  	 VBN	O
in  	in  	 IN	O
4  	4  	 CD	O
×  	×  	 CD	O
1  	1  	 CD	O
ml  	ml  	 NN	O
of  	of  	 IN	O
GLB  	GLB  	 NNP	B-NP
buffer  	buffer  	 NN	I-NP
and  	and  	 CC	O
then  	then  	 RB	O
in  	in  	 IN	O
2  	2  	 CD	O
×  	×  	 CD	O
1  	1  	 CD	O
ml  	ml  	 NN	O
of  	of  	 IN	O
KGB  	KGB  	 NNP	B-NP
buffer 	buffer 	 NN	I-NP
.  	.  	 .	O
Kinase  	Kinase  	 JJ	B-NP
reactions  	reactions  	 NNS	I-NP
contained  	contained  	 VBD	O
5  	5  	 CD	O
μM  	μM  	 JJ	B-NP
ATP 	ATP 	 NNP	I-NP
/ 	/ 	 CD	O
15  	15  	 CD	O
μCi  	μCi  	 JJ	O
32P-ATP 	32P-ATP 	 CD	O
/ 	/ 	 CD	O
0.5  	0.5  	 CD	O
μg  	μg  	 CD	B-NP
PhosphoCREB  	PhosphoCREB  	 JJ	I-NP
peptide  	peptide  	 NN	I-NP
in  	in  	 IN	O
30  	30  	 CD	O
μl  	μl  	 NN	B-NP
of  	of  	 IN	I-NP
KGB 	KGB 	 NNP	I-NP
.  	.  	 .	O
After  	After  	 IN	O
incubate  	incubate  	 NN	B-NP
for  	for  	 IN	O
10  	10  	 CD	O
min  	min  	 NN	B-NP
at  	at  	 IN	O
room  	room  	 NN	B-NP
temperature 	temperature 	 NN	I-NP
,  	,  	 ,	O
the  	the  	 DT	O
beads  	beads  	 NN	O
were  	were  	 VBD	O
collected  	collected  	 VBN	O
by  	by  	 IN	O
centrifugation  	centrifugation  	 NN	B-NP
and  	and  	 CC	O
20  	20  	 CD	O
μl  	μl  	 NN	B-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
reaction  	reaction  	 NN	I-NP
mix  	mix  	 NN	I-NP
spotted  	spotted  	 VBD	O
onto  	onto  	 IN	O
circles  	circles  	 NNS	O
of  	of  	 IN	O
P81  	P81  	 CD	B-NP
paper  	paper  	 NN	I-NP
( 	( 	 -LRB-	O
Whatman 	Whatman 	 NNP	B-NP
,  	,  	 ,	O
USA 	USA 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
P81  	P81  	 JJ	B-NP
paper  	paper  	 NN	I-NP
was  	was  	 VBD	O
washed  	washed  	 VBN	O
in  	in  	 IN	O
4  	4  	 CD	O
×  	×  	 CD	O
10  	10  	 CD	O
ml  	ml  	 CD	O
changes  	changes  	 NNS	O
of  	of  	 IN	O
100  	100  	 CD	O
mM  	mM  	 JJ	O
phosphoric  	phosphoric  	 JJ	B-NP
acid 	acid 	 NN	I-NP
,  	,  	 ,	O
dried  	dried  	 VBN	O
and  	and  	 CC	O
counted 	counted 	 VBN	O
.  	.  	 .	O
PhosphoCREB  	PhosphoCREB  	 JJ	B-NP
peptide  	peptide  	 NNS	I-NP
( 	( 	 -LRB-	I-NP
sequence  	sequence  	 FW	I-NP
KRREILSRRPS 	KRREILSRRPS 	 FW	I-NP
( 	( 	 -LRB-	I-NP
P 	P 	 NN	I-NP
) 	) 	 -RRB-	I-NP
YR 	YR 	 NNP	I-NP
)  	)  	 -RRB-	O
was  	was  	 VBD	O
obtained  	obtained  	 VBN	O
from  	from  	 IN	O
New  	New  	 NNP	B-NP
England  	England  	 NNP	I-NP
Biolabs 	Biolabs 	 NNP	I-NP
,  	,  	 ,	O
MA 	MA 	 NNP	O
.  	.  	 .	O
Mutagenesis  	Mutagenesis  	 NNP	B-NP
was  	was  	 VBD	O
carried  	carried  	 VBN	O
out  	out  	 RP	O
using  	using  	 VBG	O
the  	the  	 DT	O
Altered  	Altered  	 NNP	O
Sites  	Sites  	 NNP	O
Mutagenesis  	Mutagenesis  	 NNP	B-NP
System  	System  	 NNP	I-NP
( 	( 	 -LRB-	O
Promega 	Promega 	 NNP	B-NP
,  	,  	 ,	O
Wl 	Wl 	 NNP	B-NP
)  	)  	 -RRB-	O
as  	as  	 IN	O
previously  	previously  	 RB	O
described  	described  	 VBN	O
by  	by  	 IN	O
us  	us  	 PRP	O
[  	[  	 -LRB-	O
33 	33 	 CD	O
] 	] 	 -RRB-	O
.  	.  	 .	O
Human  	Human  	 JJ	B-NP
wild  	wild  	 JJ	I-NP
type  	type  	 NN	I-NP
p53  	p53  	 NN	I-NP
or  	or  	 CC	O
p53  	p53  	 NN	B-NP
bearing  	bearing  	 NN	I-NP
mutations  	mutations  	 NNS	I-NP
in  	in  	 IN	O
serines  	serines  	 CD	B-NP
33  	33  	 CD	O
or  	or  	 CC	O
37  	37  	 CD	O
were  	were  	 VBD	O
inserted  	inserted  	 VBN	O
into  	into  	 IN	O
the  	the  	 DT	O
BamH1  	BamH1  	 JJ	B-NP
site  	site  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
pcDNA3.1  	pcDNA3.1  	 JJ	O
expression  	expression  	 NN	B-NP
vector  	vector  	 NN	I-NP
( 	( 	 -LRB-	O
Invitrogen 	Invitrogen 	 NNP	B-NP
,  	,  	 ,	O
CA 	CA 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
Luciferase  	Luciferase  	 JJ	B-NP
reporter  	reporter  	 NN	I-NP
assays  	assays  	 NNS	I-NP
were  	were  	 VBD	O
carried  	carried  	 VBN	O
out  	out  	 RP	O
in  	in  	 IN	O
the  	the  	 DT	O
p53  	p53  	 NN	B-NP
null  	null  	 NN	O
cell  	cell  	 NN	B-NP
line  	line  	 NN	I-NP
SAOS-2  	SAOS-2  	 VBZ	I-NP
using  	using  	 VBG	O
the  	the  	 DT	O
p53  	p53  	 NN	B-NP
specific  	specific  	 JJ	O
luciferase  	luciferase  	 JJ	B-NP
reporter  	reporter  	 NN	I-NP
construct  	construct  	 VBD	O
p50-Luc 	p50-Luc 	 CD	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
pCMV-β-galatosidase  	pCMV-β-galatosidase  	 JJ	B-NP
to  	to  	 TO	O
control  	control  	 VB	O
for  	for  	 IN	O
transfection  	transfection  	 JJ	B-NP
efficiency 	efficiency 	 NN	I-NP
.  	.  	 .	O
Cells  	Cells  	 NNS	O
were  	were  	 VBD	O
transfected  	transfected  	 VBN	O
using  	using  	 VBG	O
Lipofectin  	Lipofectin  	 NNP	B-NP
( 	( 	 -LRB-	O
Gibco-BRL 	Gibco-BRL 	 NNP	B-NP
)  	)  	 -RRB-	O
containing  	containing  	 VBG	B-NP
p50-Luc  	p50-Luc  	 NNP	I-NP
( 	( 	 -LRB-	O
1  	1  	 CD	O
μg 	μg 	 CD	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
pCMV-Gal  	pCMV-Gal  	 NNP	B-NP
( 	( 	 -LRB-	O
1  	1  	 CD	O
μg 	μg 	 CD	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
pcDNAp53  	pcDNAp53  	 NNP	B-NP
( 	( 	 -LRB-	O
50  	50  	 CD	O
ng 	ng 	 CD	B-NP
)  	)  	 -RRB-	O
in  	in  	 IN	O
a  	a  	 DT	O
final  	final  	 JJ	B-NP
volume  	volume  	 NN	I-NP
of  	of  	 IN	O
400  	400  	 CD	O
μl  	μl  	 NNS	B-NP
as  	as  	 RB	O
described  	described  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
manufacturers  	manufacturers  	 NNS	B-NP
protocol 	protocol 	 NN	I-NP
.  	.  	 .	O
